<?xml version="1.0" encoding="UTF-8"?>
<SAMPLE_SET xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <SAMPLE alias="SAMEA5883825" accession="ERS3672281">
    <IDENTIFIERS>
      <PRIMARY_ID>ERS3672281</PRIMARY_ID>
      <EXTERNAL_ID namespace="BioSample">SAMEA5883825</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>PR030_S10</TITLE>
    <SAMPLE_NAME>
      <TAXON_ID>9606</TAXON_ID>
      <SCIENTIFIC_NAME>Homo sapiens</SCIENTIFIC_NAME>
    </SAMPLE_NAME>
    <DESCRIPTION>Protocols: Close contacts of patients with active tuberculosis (TB) were recruited from multiple TB clinics in London. At enrolment, peripheral blood RNA was collected into Tempus tubes. Total blood RNA was extracted using the Tempus Spin RNA Isolation Kit (Ambion; Life Technologies). Globin mRNA and genomic DNA were removed using the GlobinClear kit (Life Technologies) and the TURBO DNAfree kit (Ambion, Life Technologies), respectively. cDNA libraries were generated using the Kapa mRNA Hyperprep kit (Roche).</DESCRIPTION>
    <SAMPLE_ATTRIBUTES>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-FIRST-PUBLIC</TAG>
        <VALUE>2019-08-23T17:03:50Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-LAST-UPDATE</TAG>
        <VALUE>2019-08-23T10:24:58Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>External Id</TAG>
        <VALUE>SAMEA5883825</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC center name</TAG>
        <VALUE>UCL Infection&amp;Immunity Division</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC first public</TAG>
        <VALUE>2019-08-23T17:03:50Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC last update</TAG>
        <VALUE>2019-08-23T10:24:58Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC status</TAG>
        <VALUE>public</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>Submitter Id</TAG>
        <VALUE>E-MTAB-68451566551630:PR030_S10</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>age</TAG>
        <VALUE>29</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>broker name</TAG>
        <VALUE>ArrayExpress</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>common name</TAG>
        <VALUE>human</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>interferon gamma release assay</TAG>
        <VALUE>positive</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>organism part</TAG>
        <VALUE>blood</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>preventative tuberculosis treatment</TAG>
        <VALUE>yes</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>progressor status (median follow-up 1.9 years)</TAG>
        <VALUE>non-progressor</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>progressor status (median follow-up 346 days)</TAG>
        <VALUE>non-progressor</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>roe et al 2019 subset (median follow-up 346 days)</TAG>
        <VALUE>yes</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sample name</TAG>
        <VALUE>E-MTAB-68451566551630:PR030_S10</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>scientific_name</TAG>
        <VALUE>Homo sapiens</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sex</TAG>
        <VALUE>male</VALUE>
      </SAMPLE_ATTRIBUTE>
    </SAMPLE_ATTRIBUTES>
  </SAMPLE>
  <SAMPLE alias="SAMEA5883826" accession="ERS3672282">
    <IDENTIFIERS>
      <PRIMARY_ID>ERS3672282</PRIMARY_ID>
      <EXTERNAL_ID namespace="BioSample">SAMEA5883826</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>PR156_S6</TITLE>
    <SAMPLE_NAME>
      <TAXON_ID>9606</TAXON_ID>
      <SCIENTIFIC_NAME>Homo sapiens</SCIENTIFIC_NAME>
    </SAMPLE_NAME>
    <DESCRIPTION>Protocols: Close contacts of patients with active tuberculosis (TB) were recruited from multiple TB clinics in London. At enrolment, peripheral blood RNA was collected into Tempus tubes. Total blood RNA was extracted using the Tempus Spin RNA Isolation Kit (Ambion; Life Technologies). Globin mRNA and genomic DNA were removed using the GlobinClear kit (Life Technologies) and the TURBO DNAfree kit (Ambion, Life Technologies), respectively. cDNA libraries were generated using the Kapa mRNA Hyperprep kit (Roche).</DESCRIPTION>
    <SAMPLE_ATTRIBUTES>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-FIRST-PUBLIC</TAG>
        <VALUE>2019-08-23T17:03:50Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-LAST-UPDATE</TAG>
        <VALUE>2019-08-23T10:24:58Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>External Id</TAG>
        <VALUE>SAMEA5883826</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC center name</TAG>
        <VALUE>UCL Infection&amp;Immunity Division</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC first public</TAG>
        <VALUE>2019-08-23T17:03:50Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC last update</TAG>
        <VALUE>2019-08-23T10:24:58Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC status</TAG>
        <VALUE>public</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>Submitter Id</TAG>
        <VALUE>E-MTAB-68451566551630:PR156_S6</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>age</TAG>
        <VALUE>32</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>broker name</TAG>
        <VALUE>ArrayExpress</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>common name</TAG>
        <VALUE>human</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>interferon gamma release assay</TAG>
        <VALUE>positive</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>organism part</TAG>
        <VALUE>blood</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>preventative tuberculosis treatment</TAG>
        <VALUE>yes</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>progressor status (median follow-up 1.9 years)</TAG>
        <VALUE>non-progressor</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>progressor status (median follow-up 346 days)</TAG>
        <VALUE>non-progressor</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>roe et al 2019 subset (median follow-up 346 days)</TAG>
        <VALUE>yes</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sample name</TAG>
        <VALUE>E-MTAB-68451566551630:PR156_S6</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>scientific_name</TAG>
        <VALUE>Homo sapiens</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sex</TAG>
        <VALUE>female</VALUE>
      </SAMPLE_ATTRIBUTE>
    </SAMPLE_ATTRIBUTES>
  </SAMPLE>
  <SAMPLE alias="SAMEA5883827" accession="ERS3672283">
    <IDENTIFIERS>
      <PRIMARY_ID>ERS3672283</PRIMARY_ID>
      <EXTERNAL_ID namespace="BioSample">SAMEA5883827</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>PR060_S23</TITLE>
    <SAMPLE_NAME>
      <TAXON_ID>9606</TAXON_ID>
      <SCIENTIFIC_NAME>Homo sapiens</SCIENTIFIC_NAME>
    </SAMPLE_NAME>
    <DESCRIPTION>Protocols: Close contacts of patients with active tuberculosis (TB) were recruited from multiple TB clinics in London. At enrolment, peripheral blood RNA was collected into Tempus tubes. Total blood RNA was extracted using the Tempus Spin RNA Isolation Kit (Ambion; Life Technologies). Globin mRNA and genomic DNA were removed using the GlobinClear kit (Life Technologies) and the TURBO DNAfree kit (Ambion, Life Technologies), respectively. cDNA libraries were generated using the Kapa mRNA Hyperprep kit (Roche).</DESCRIPTION>
    <SAMPLE_ATTRIBUTES>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-FIRST-PUBLIC</TAG>
        <VALUE>2019-08-23T17:03:50Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-LAST-UPDATE</TAG>
        <VALUE>2019-08-23T10:24:58Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>External Id</TAG>
        <VALUE>SAMEA5883827</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC center name</TAG>
        <VALUE>UCL Infection&amp;Immunity Division</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC first public</TAG>
        <VALUE>2019-08-23T17:03:50Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC last update</TAG>
        <VALUE>2019-08-23T10:24:58Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC status</TAG>
        <VALUE>public</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>Submitter Id</TAG>
        <VALUE>E-MTAB-68451566551630:PR060_S23</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>age</TAG>
        <VALUE>28</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>broker name</TAG>
        <VALUE>ArrayExpress</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>common name</TAG>
        <VALUE>human</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>interferon gamma release assay</TAG>
        <VALUE>positive</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>organism part</TAG>
        <VALUE>blood</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>preventative tuberculosis treatment</TAG>
        <VALUE>yes</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>progressor status (median follow-up 1.9 years)</TAG>
        <VALUE>non-progressor</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>progressor status (median follow-up 346 days)</TAG>
        <VALUE>non-progressor</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>roe et al 2019 subset (median follow-up 346 days)</TAG>
        <VALUE>yes</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sample name</TAG>
        <VALUE>E-MTAB-68451566551630:PR060_S23</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>scientific_name</TAG>
        <VALUE>Homo sapiens</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sex</TAG>
        <VALUE>female</VALUE>
      </SAMPLE_ATTRIBUTE>
    </SAMPLE_ATTRIBUTES>
  </SAMPLE>
  <SAMPLE alias="SAMEA5883828" accession="ERS3672284">
    <IDENTIFIERS>
      <PRIMARY_ID>ERS3672284</PRIMARY_ID>
      <EXTERNAL_ID namespace="BioSample">SAMEA5883828</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>PR042_S21</TITLE>
    <SAMPLE_NAME>
      <TAXON_ID>9606</TAXON_ID>
      <SCIENTIFIC_NAME>Homo sapiens</SCIENTIFIC_NAME>
    </SAMPLE_NAME>
    <DESCRIPTION>Protocols: Close contacts of patients with active tuberculosis (TB) were recruited from multiple TB clinics in London. At enrolment, peripheral blood RNA was collected into Tempus tubes. Total blood RNA was extracted using the Tempus Spin RNA Isolation Kit (Ambion; Life Technologies). Globin mRNA and genomic DNA were removed using the GlobinClear kit (Life Technologies) and the TURBO DNAfree kit (Ambion, Life Technologies), respectively. cDNA libraries were generated using the Kapa mRNA Hyperprep kit (Roche).</DESCRIPTION>
    <SAMPLE_ATTRIBUTES>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-FIRST-PUBLIC</TAG>
        <VALUE>2019-08-23T17:03:50Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-LAST-UPDATE</TAG>
        <VALUE>2019-08-23T10:24:58Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>External Id</TAG>
        <VALUE>SAMEA5883828</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC center name</TAG>
        <VALUE>UCL Infection&amp;Immunity Division</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC first public</TAG>
        <VALUE>2019-08-23T17:03:50Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC last update</TAG>
        <VALUE>2019-08-23T10:24:58Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC status</TAG>
        <VALUE>public</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>Submitter Id</TAG>
        <VALUE>E-MTAB-68451566551630:PR042_S21</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>age</TAG>
        <VALUE>21</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>broker name</TAG>
        <VALUE>ArrayExpress</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>common name</TAG>
        <VALUE>human</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>interferon gamma release assay</TAG>
        <VALUE>positive</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>organism part</TAG>
        <VALUE>blood</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>preventative tuberculosis treatment</TAG>
        <VALUE>yes</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>progressor status (median follow-up 1.9 years)</TAG>
        <VALUE>non-progressor</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>progressor status (median follow-up 346 days)</TAG>
        <VALUE>non-progressor</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>roe et al 2019 subset (median follow-up 346 days)</TAG>
        <VALUE>yes</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sample name</TAG>
        <VALUE>E-MTAB-68451566551630:PR042_S21</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>scientific_name</TAG>
        <VALUE>Homo sapiens</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sex</TAG>
        <VALUE>male</VALUE>
      </SAMPLE_ATTRIBUTE>
    </SAMPLE_ATTRIBUTES>
  </SAMPLE>
  <SAMPLE alias="SAMEA5883829" accession="ERS3672285">
    <IDENTIFIERS>
      <PRIMARY_ID>ERS3672285</PRIMARY_ID>
      <EXTERNAL_ID namespace="BioSample">SAMEA5883829</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>PR075_S10</TITLE>
    <SAMPLE_NAME>
      <TAXON_ID>9606</TAXON_ID>
      <SCIENTIFIC_NAME>Homo sapiens</SCIENTIFIC_NAME>
    </SAMPLE_NAME>
    <DESCRIPTION>Protocols: Close contacts of patients with active tuberculosis (TB) were recruited from multiple TB clinics in London. At enrolment, peripheral blood RNA was collected into Tempus tubes. Total blood RNA was extracted using the Tempus Spin RNA Isolation Kit (Ambion; Life Technologies). Globin mRNA and genomic DNA were removed using the GlobinClear kit (Life Technologies) and the TURBO DNAfree kit (Ambion, Life Technologies), respectively. cDNA libraries were generated using the Kapa mRNA Hyperprep kit (Roche).</DESCRIPTION>
    <SAMPLE_ATTRIBUTES>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-FIRST-PUBLIC</TAG>
        <VALUE>2019-08-23T17:03:50Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-LAST-UPDATE</TAG>
        <VALUE>2019-08-23T10:24:58Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>External Id</TAG>
        <VALUE>SAMEA5883829</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC center name</TAG>
        <VALUE>UCL Infection&amp;Immunity Division</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC first public</TAG>
        <VALUE>2019-08-23T17:03:50Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC last update</TAG>
        <VALUE>2019-08-23T10:24:58Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC status</TAG>
        <VALUE>public</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>Submitter Id</TAG>
        <VALUE>E-MTAB-68451566551630:PR075_S10</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>age</TAG>
        <VALUE>32</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>broker name</TAG>
        <VALUE>ArrayExpress</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>common name</TAG>
        <VALUE>human</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>interferon gamma release assay</TAG>
        <VALUE>positive</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>organism part</TAG>
        <VALUE>blood</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>preventative tuberculosis treatment</TAG>
        <VALUE>yes</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>progressor status (median follow-up 1.9 years)</TAG>
        <VALUE>non-progressor</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>progressor status (median follow-up 346 days)</TAG>
        <VALUE>non-progressor</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>roe et al 2019 subset (median follow-up 346 days)</TAG>
        <VALUE>yes</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sample name</TAG>
        <VALUE>E-MTAB-68451566551630:PR075_S10</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>scientific_name</TAG>
        <VALUE>Homo sapiens</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sex</TAG>
        <VALUE>male</VALUE>
      </SAMPLE_ATTRIBUTE>
    </SAMPLE_ATTRIBUTES>
  </SAMPLE>
  <SAMPLE alias="SAMEA5883830" accession="ERS3672286">
    <IDENTIFIERS>
      <PRIMARY_ID>ERS3672286</PRIMARY_ID>
      <EXTERNAL_ID namespace="BioSample">SAMEA5883830</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>PR045_S17</TITLE>
    <SAMPLE_NAME>
      <TAXON_ID>9606</TAXON_ID>
      <SCIENTIFIC_NAME>Homo sapiens</SCIENTIFIC_NAME>
    </SAMPLE_NAME>
    <DESCRIPTION>Protocols: Close contacts of patients with active tuberculosis (TB) were recruited from multiple TB clinics in London. At enrolment, peripheral blood RNA was collected into Tempus tubes. Total blood RNA was extracted using the Tempus Spin RNA Isolation Kit (Ambion; Life Technologies). Globin mRNA and genomic DNA were removed using the GlobinClear kit (Life Technologies) and the TURBO DNAfree kit (Ambion, Life Technologies), respectively. cDNA libraries were generated using the Kapa mRNA Hyperprep kit (Roche).</DESCRIPTION>
    <SAMPLE_ATTRIBUTES>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-FIRST-PUBLIC</TAG>
        <VALUE>2019-08-23T17:03:50Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-LAST-UPDATE</TAG>
        <VALUE>2019-08-23T10:24:58Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>External Id</TAG>
        <VALUE>SAMEA5883830</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC center name</TAG>
        <VALUE>UCL Infection&amp;Immunity Division</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC first public</TAG>
        <VALUE>2019-08-23T17:03:50Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC last update</TAG>
        <VALUE>2019-08-23T10:24:58Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC status</TAG>
        <VALUE>public</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>Submitter Id</TAG>
        <VALUE>E-MTAB-68451566551630:PR045_S17</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>age</TAG>
        <VALUE>19</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>broker name</TAG>
        <VALUE>ArrayExpress</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>common name</TAG>
        <VALUE>human</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>interferon gamma release assay</TAG>
        <VALUE>positive</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>organism part</TAG>
        <VALUE>blood</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>preventative tuberculosis treatment</TAG>
        <VALUE>yes</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>progressor status (median follow-up 1.9 years)</TAG>
        <VALUE>non-progressor</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>progressor status (median follow-up 346 days)</TAG>
        <VALUE>non-progressor</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>roe et al 2019 subset (median follow-up 346 days)</TAG>
        <VALUE>yes</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sample name</TAG>
        <VALUE>E-MTAB-68451566551630:PR045_S17</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>scientific_name</TAG>
        <VALUE>Homo sapiens</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sex</TAG>
        <VALUE>female</VALUE>
      </SAMPLE_ATTRIBUTE>
    </SAMPLE_ATTRIBUTES>
  </SAMPLE>
  <SAMPLE alias="SAMEA5883831" accession="ERS3672287">
    <IDENTIFIERS>
      <PRIMARY_ID>ERS3672287</PRIMARY_ID>
      <EXTERNAL_ID namespace="BioSample">SAMEA5883831</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>PR149_S23</TITLE>
    <SAMPLE_NAME>
      <TAXON_ID>9606</TAXON_ID>
      <SCIENTIFIC_NAME>Homo sapiens</SCIENTIFIC_NAME>
    </SAMPLE_NAME>
    <DESCRIPTION>Protocols: Close contacts of patients with active tuberculosis (TB) were recruited from multiple TB clinics in London. At enrolment, peripheral blood RNA was collected into Tempus tubes. Total blood RNA was extracted using the Tempus Spin RNA Isolation Kit (Ambion; Life Technologies). Globin mRNA and genomic DNA were removed using the GlobinClear kit (Life Technologies) and the TURBO DNAfree kit (Ambion, Life Technologies), respectively. cDNA libraries were generated using the Kapa mRNA Hyperprep kit (Roche).</DESCRIPTION>
    <SAMPLE_ATTRIBUTES>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-FIRST-PUBLIC</TAG>
        <VALUE>2019-08-23T17:03:50Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-LAST-UPDATE</TAG>
        <VALUE>2019-08-23T10:24:58Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>External Id</TAG>
        <VALUE>SAMEA5883831</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC center name</TAG>
        <VALUE>UCL Infection&amp;Immunity Division</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC first public</TAG>
        <VALUE>2019-08-23T17:03:50Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC last update</TAG>
        <VALUE>2019-08-23T10:24:58Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC status</TAG>
        <VALUE>public</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>Submitter Id</TAG>
        <VALUE>E-MTAB-68451566551630:PR149_S23</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>age</TAG>
        <VALUE>26</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>broker name</TAG>
        <VALUE>ArrayExpress</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>common name</TAG>
        <VALUE>human</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>interferon gamma release assay</TAG>
        <VALUE>positive</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>organism part</TAG>
        <VALUE>blood</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>preventative tuberculosis treatment</TAG>
        <VALUE>yes</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>progressor status (median follow-up 1.9 years)</TAG>
        <VALUE>non-progressor</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>progressor status (median follow-up 346 days)</TAG>
        <VALUE>non-progressor</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>roe et al 2019 subset (median follow-up 346 days)</TAG>
        <VALUE>yes</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sample name</TAG>
        <VALUE>E-MTAB-68451566551630:PR149_S23</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>scientific_name</TAG>
        <VALUE>Homo sapiens</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sex</TAG>
        <VALUE>male</VALUE>
      </SAMPLE_ATTRIBUTE>
    </SAMPLE_ATTRIBUTES>
  </SAMPLE>
  <SAMPLE alias="SAMEA5883832" accession="ERS3672288">
    <IDENTIFIERS>
      <PRIMARY_ID>ERS3672288</PRIMARY_ID>
      <EXTERNAL_ID namespace="BioSample">SAMEA5883832</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>PR119_S7</TITLE>
    <SAMPLE_NAME>
      <TAXON_ID>9606</TAXON_ID>
      <SCIENTIFIC_NAME>Homo sapiens</SCIENTIFIC_NAME>
    </SAMPLE_NAME>
    <DESCRIPTION>Protocols: Close contacts of patients with active tuberculosis (TB) were recruited from multiple TB clinics in London. At enrolment, peripheral blood RNA was collected into Tempus tubes. Total blood RNA was extracted using the Tempus Spin RNA Isolation Kit (Ambion; Life Technologies). Globin mRNA and genomic DNA were removed using the GlobinClear kit (Life Technologies) and the TURBO DNAfree kit (Ambion, Life Technologies), respectively. cDNA libraries were generated using the Kapa mRNA Hyperprep kit (Roche).</DESCRIPTION>
    <SAMPLE_ATTRIBUTES>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-FIRST-PUBLIC</TAG>
        <VALUE>2019-08-23T17:03:50Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-LAST-UPDATE</TAG>
        <VALUE>2019-08-23T10:24:58Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>External Id</TAG>
        <VALUE>SAMEA5883832</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC center name</TAG>
        <VALUE>UCL Infection&amp;Immunity Division</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC first public</TAG>
        <VALUE>2019-08-23T17:03:50Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC last update</TAG>
        <VALUE>2019-08-23T10:24:58Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC status</TAG>
        <VALUE>public</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>Submitter Id</TAG>
        <VALUE>E-MTAB-68451566551630:PR119_S7</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>age</TAG>
        <VALUE>30</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>broker name</TAG>
        <VALUE>ArrayExpress</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>common name</TAG>
        <VALUE>human</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>interferon gamma release assay</TAG>
        <VALUE>positive</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>organism part</TAG>
        <VALUE>blood</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>preventative tuberculosis treatment</TAG>
        <VALUE>yes</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>progressor status (median follow-up 1.9 years)</TAG>
        <VALUE>non-progressor</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>progressor status (median follow-up 346 days)</TAG>
        <VALUE>non-progressor</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>roe et al 2019 subset (median follow-up 346 days)</TAG>
        <VALUE>yes</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sample name</TAG>
        <VALUE>E-MTAB-68451566551630:PR119_S7</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>scientific_name</TAG>
        <VALUE>Homo sapiens</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sex</TAG>
        <VALUE>female</VALUE>
      </SAMPLE_ATTRIBUTE>
    </SAMPLE_ATTRIBUTES>
  </SAMPLE>
  <SAMPLE alias="SAMEA5883833" accession="ERS3672289">
    <IDENTIFIERS>
      <PRIMARY_ID>ERS3672289</PRIMARY_ID>
      <EXTERNAL_ID namespace="BioSample">SAMEA5883833</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>PR086_S8</TITLE>
    <SAMPLE_NAME>
      <TAXON_ID>9606</TAXON_ID>
      <SCIENTIFIC_NAME>Homo sapiens</SCIENTIFIC_NAME>
    </SAMPLE_NAME>
    <DESCRIPTION>Protocols: Close contacts of patients with active tuberculosis (TB) were recruited from multiple TB clinics in London. At enrolment, peripheral blood RNA was collected into Tempus tubes. Total blood RNA was extracted using the Tempus Spin RNA Isolation Kit (Ambion; Life Technologies). Globin mRNA and genomic DNA were removed using the GlobinClear kit (Life Technologies) and the TURBO DNAfree kit (Ambion, Life Technologies), respectively. cDNA libraries were generated using the Kapa mRNA Hyperprep kit (Roche).</DESCRIPTION>
    <SAMPLE_ATTRIBUTES>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-FIRST-PUBLIC</TAG>
        <VALUE>2019-08-23T17:03:50Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-LAST-UPDATE</TAG>
        <VALUE>2019-08-23T10:24:58Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>External Id</TAG>
        <VALUE>SAMEA5883833</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC center name</TAG>
        <VALUE>UCL Infection&amp;Immunity Division</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC first public</TAG>
        <VALUE>2019-08-23T17:03:50Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC last update</TAG>
        <VALUE>2019-08-23T10:24:58Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC status</TAG>
        <VALUE>public</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>Submitter Id</TAG>
        <VALUE>E-MTAB-68451566551630:PR086_S8</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>age</TAG>
        <VALUE>33</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>broker name</TAG>
        <VALUE>ArrayExpress</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>common name</TAG>
        <VALUE>human</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>interferon gamma release assay</TAG>
        <VALUE>positive</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>organism part</TAG>
        <VALUE>blood</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>preventative tuberculosis treatment</TAG>
        <VALUE>yes</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>progressor status (median follow-up 1.9 years)</TAG>
        <VALUE>non-progressor</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>progressor status (median follow-up 346 days)</TAG>
        <VALUE>non-progressor</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>roe et al 2019 subset (median follow-up 346 days)</TAG>
        <VALUE>yes</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sample name</TAG>
        <VALUE>E-MTAB-68451566551630:PR086_S8</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>scientific_name</TAG>
        <VALUE>Homo sapiens</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sex</TAG>
        <VALUE>male</VALUE>
      </SAMPLE_ATTRIBUTE>
    </SAMPLE_ATTRIBUTES>
  </SAMPLE>
  <SAMPLE alias="SAMEA5883834" accession="ERS3672290">
    <IDENTIFIERS>
      <PRIMARY_ID>ERS3672290</PRIMARY_ID>
      <EXTERNAL_ID namespace="BioSample">SAMEA5883834</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>PR058_S15</TITLE>
    <SAMPLE_NAME>
      <TAXON_ID>9606</TAXON_ID>
      <SCIENTIFIC_NAME>Homo sapiens</SCIENTIFIC_NAME>
    </SAMPLE_NAME>
    <DESCRIPTION>Protocols: Close contacts of patients with active tuberculosis (TB) were recruited from multiple TB clinics in London. At enrolment, peripheral blood RNA was collected into Tempus tubes. Total blood RNA was extracted using the Tempus Spin RNA Isolation Kit (Ambion; Life Technologies). Globin mRNA and genomic DNA were removed using the GlobinClear kit (Life Technologies) and the TURBO DNAfree kit (Ambion, Life Technologies), respectively. cDNA libraries were generated using the Kapa mRNA Hyperprep kit (Roche).</DESCRIPTION>
    <SAMPLE_ATTRIBUTES>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-FIRST-PUBLIC</TAG>
        <VALUE>2019-08-23T17:03:50Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-LAST-UPDATE</TAG>
        <VALUE>2019-08-23T10:24:58Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>External Id</TAG>
        <VALUE>SAMEA5883834</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC center name</TAG>
        <VALUE>UCL Infection&amp;Immunity Division</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC first public</TAG>
        <VALUE>2019-08-23T17:03:50Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC last update</TAG>
        <VALUE>2019-08-23T10:24:58Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC status</TAG>
        <VALUE>public</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>Submitter Id</TAG>
        <VALUE>E-MTAB-68451566551630:PR058_S15</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>age</TAG>
        <VALUE>31</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>broker name</TAG>
        <VALUE>ArrayExpress</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>common name</TAG>
        <VALUE>human</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>interferon gamma release assay</TAG>
        <VALUE>positive</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>organism part</TAG>
        <VALUE>blood</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>preventative tuberculosis treatment</TAG>
        <VALUE>yes</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>progressor status (median follow-up 1.9 years)</TAG>
        <VALUE>non-progressor</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>progressor status (median follow-up 346 days)</TAG>
        <VALUE>non-progressor</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>roe et al 2019 subset (median follow-up 346 days)</TAG>
        <VALUE>yes</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sample name</TAG>
        <VALUE>E-MTAB-68451566551630:PR058_S15</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>scientific_name</TAG>
        <VALUE>Homo sapiens</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sex</TAG>
        <VALUE>male</VALUE>
      </SAMPLE_ATTRIBUTE>
    </SAMPLE_ATTRIBUTES>
  </SAMPLE>
  <SAMPLE alias="SAMEA5883835" accession="ERS3672291">
    <IDENTIFIERS>
      <PRIMARY_ID>ERS3672291</PRIMARY_ID>
      <EXTERNAL_ID namespace="BioSample">SAMEA5883835</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>PR059_S1</TITLE>
    <SAMPLE_NAME>
      <TAXON_ID>9606</TAXON_ID>
      <SCIENTIFIC_NAME>Homo sapiens</SCIENTIFIC_NAME>
    </SAMPLE_NAME>
    <DESCRIPTION>Protocols: Close contacts of patients with active tuberculosis (TB) were recruited from multiple TB clinics in London. At enrolment, peripheral blood RNA was collected into Tempus tubes. Total blood RNA was extracted using the Tempus Spin RNA Isolation Kit (Ambion; Life Technologies). Globin mRNA and genomic DNA were removed using the GlobinClear kit (Life Technologies) and the TURBO DNAfree kit (Ambion, Life Technologies), respectively. cDNA libraries were generated using the Kapa mRNA Hyperprep kit (Roche).</DESCRIPTION>
    <SAMPLE_ATTRIBUTES>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-FIRST-PUBLIC</TAG>
        <VALUE>2019-08-23T17:03:50Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-LAST-UPDATE</TAG>
        <VALUE>2019-08-23T10:24:58Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>External Id</TAG>
        <VALUE>SAMEA5883835</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC center name</TAG>
        <VALUE>UCL Infection&amp;Immunity Division</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC first public</TAG>
        <VALUE>2019-08-23T17:03:50Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC last update</TAG>
        <VALUE>2019-08-23T10:24:58Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC status</TAG>
        <VALUE>public</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>Submitter Id</TAG>
        <VALUE>E-MTAB-68451566551630:PR059_S1</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>age</TAG>
        <VALUE>22</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>broker name</TAG>
        <VALUE>ArrayExpress</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>common name</TAG>
        <VALUE>human</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>interferon gamma release assay</TAG>
        <VALUE>positive</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>organism part</TAG>
        <VALUE>blood</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>preventative tuberculosis treatment</TAG>
        <VALUE>yes</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>progressor status (median follow-up 1.9 years)</TAG>
        <VALUE>non-progressor</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>progressor status (median follow-up 346 days)</TAG>
        <VALUE>non-progressor</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>roe et al 2019 subset (median follow-up 346 days)</TAG>
        <VALUE>yes</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sample name</TAG>
        <VALUE>E-MTAB-68451566551630:PR059_S1</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>scientific_name</TAG>
        <VALUE>Homo sapiens</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sex</TAG>
        <VALUE>female</VALUE>
      </SAMPLE_ATTRIBUTE>
    </SAMPLE_ATTRIBUTES>
  </SAMPLE>
  <SAMPLE alias="SAMEA5883836" accession="ERS3672292">
    <IDENTIFIERS>
      <PRIMARY_ID>ERS3672292</PRIMARY_ID>
      <EXTERNAL_ID namespace="BioSample">SAMEA5883836</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>PR294_S9</TITLE>
    <SAMPLE_NAME>
      <TAXON_ID>9606</TAXON_ID>
      <SCIENTIFIC_NAME>Homo sapiens</SCIENTIFIC_NAME>
    </SAMPLE_NAME>
    <DESCRIPTION>Protocols: Close contacts of patients with active tuberculosis (TB) were recruited from multiple TB clinics in London. At enrolment, peripheral blood RNA was collected into Tempus tubes. Total blood RNA was extracted using the Tempus Spin RNA Isolation Kit (Ambion; Life Technologies). Globin mRNA and genomic DNA were removed using the GlobinClear kit (Life Technologies) and the TURBO DNAfree kit (Ambion, Life Technologies), respectively. cDNA libraries were generated using the Kapa mRNA Hyperprep kit (Roche).</DESCRIPTION>
    <SAMPLE_ATTRIBUTES>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-FIRST-PUBLIC</TAG>
        <VALUE>2019-08-23T17:03:50Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-LAST-UPDATE</TAG>
        <VALUE>2019-08-23T10:24:58Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>External Id</TAG>
        <VALUE>SAMEA5883836</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC center name</TAG>
        <VALUE>UCL Infection&amp;Immunity Division</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC first public</TAG>
        <VALUE>2019-08-23T17:03:50Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC last update</TAG>
        <VALUE>2019-08-23T10:24:58Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC status</TAG>
        <VALUE>public</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>Submitter Id</TAG>
        <VALUE>E-MTAB-68451566551630:PR294_S9</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>age</TAG>
        <VALUE>33</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>broker name</TAG>
        <VALUE>ArrayExpress</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>common name</TAG>
        <VALUE>human</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>interferon gamma release assay</TAG>
        <VALUE>positive</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>organism part</TAG>
        <VALUE>blood</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>preventative tuberculosis treatment</TAG>
        <VALUE>yes</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>progressor status (median follow-up 1.9 years)</TAG>
        <VALUE>non-progressor</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>progressor status (median follow-up 346 days)</TAG>
        <VALUE>non-progressor</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>roe et al 2019 subset (median follow-up 346 days)</TAG>
        <VALUE>yes</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sample name</TAG>
        <VALUE>E-MTAB-68451566551630:PR294_S9</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>scientific_name</TAG>
        <VALUE>Homo sapiens</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sex</TAG>
        <VALUE>male</VALUE>
      </SAMPLE_ATTRIBUTE>
    </SAMPLE_ATTRIBUTES>
  </SAMPLE>
  <SAMPLE alias="SAMEA5883837" accession="ERS3672293">
    <IDENTIFIERS>
      <PRIMARY_ID>ERS3672293</PRIMARY_ID>
      <EXTERNAL_ID namespace="BioSample">SAMEA5883837</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>PR027_S23</TITLE>
    <SAMPLE_NAME>
      <TAXON_ID>9606</TAXON_ID>
      <SCIENTIFIC_NAME>Homo sapiens</SCIENTIFIC_NAME>
    </SAMPLE_NAME>
    <DESCRIPTION>Protocols: Close contacts of patients with active tuberculosis (TB) were recruited from multiple TB clinics in London. At enrolment, peripheral blood RNA was collected into Tempus tubes. Total blood RNA was extracted using the Tempus Spin RNA Isolation Kit (Ambion; Life Technologies). Globin mRNA and genomic DNA were removed using the GlobinClear kit (Life Technologies) and the TURBO DNAfree kit (Ambion, Life Technologies), respectively. cDNA libraries were generated using the Kapa mRNA Hyperprep kit (Roche).</DESCRIPTION>
    <SAMPLE_ATTRIBUTES>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-FIRST-PUBLIC</TAG>
        <VALUE>2019-08-23T17:03:50Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-LAST-UPDATE</TAG>
        <VALUE>2019-08-23T10:24:58Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>External Id</TAG>
        <VALUE>SAMEA5883837</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC center name</TAG>
        <VALUE>UCL Infection&amp;Immunity Division</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC first public</TAG>
        <VALUE>2019-08-23T17:03:50Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC last update</TAG>
        <VALUE>2019-08-23T10:24:58Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC status</TAG>
        <VALUE>public</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>Submitter Id</TAG>
        <VALUE>E-MTAB-68451566551630:PR027_S23</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>age</TAG>
        <VALUE>19</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>broker name</TAG>
        <VALUE>ArrayExpress</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>common name</TAG>
        <VALUE>human</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>interferon gamma release assay</TAG>
        <VALUE>positive</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>organism part</TAG>
        <VALUE>blood</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>preventative tuberculosis treatment</TAG>
        <VALUE>yes</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>progressor status (median follow-up 1.9 years)</TAG>
        <VALUE>non-progressor</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>progressor status (median follow-up 346 days)</TAG>
        <VALUE>non-progressor</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>roe et al 2019 subset (median follow-up 346 days)</TAG>
        <VALUE>yes</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sample name</TAG>
        <VALUE>E-MTAB-68451566551630:PR027_S23</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>scientific_name</TAG>
        <VALUE>Homo sapiens</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sex</TAG>
        <VALUE>female</VALUE>
      </SAMPLE_ATTRIBUTE>
    </SAMPLE_ATTRIBUTES>
  </SAMPLE>
  <SAMPLE alias="SAMEA5883838" accession="ERS3672294">
    <IDENTIFIERS>
      <PRIMARY_ID>ERS3672294</PRIMARY_ID>
      <EXTERNAL_ID namespace="BioSample">SAMEA5883838</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>PR325_S9</TITLE>
    <SAMPLE_NAME>
      <TAXON_ID>9606</TAXON_ID>
      <SCIENTIFIC_NAME>Homo sapiens</SCIENTIFIC_NAME>
    </SAMPLE_NAME>
    <DESCRIPTION>Protocols: Close contacts of patients with active tuberculosis (TB) were recruited from multiple TB clinics in London. At enrolment, peripheral blood RNA was collected into Tempus tubes. Total blood RNA was extracted using the Tempus Spin RNA Isolation Kit (Ambion; Life Technologies). Globin mRNA and genomic DNA were removed using the GlobinClear kit (Life Technologies) and the TURBO DNAfree kit (Ambion, Life Technologies), respectively. cDNA libraries were generated using the Kapa mRNA Hyperprep kit (Roche).</DESCRIPTION>
    <SAMPLE_ATTRIBUTES>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-FIRST-PUBLIC</TAG>
        <VALUE>2019-08-23T17:03:50Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-LAST-UPDATE</TAG>
        <VALUE>2019-08-23T10:24:58Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>External Id</TAG>
        <VALUE>SAMEA5883838</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC center name</TAG>
        <VALUE>UCL Infection&amp;Immunity Division</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC first public</TAG>
        <VALUE>2019-08-23T17:03:50Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC last update</TAG>
        <VALUE>2019-08-23T10:24:58Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC status</TAG>
        <VALUE>public</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>Submitter Id</TAG>
        <VALUE>E-MTAB-68451566551630:PR325_S9</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>age</TAG>
        <VALUE>49</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>broker name</TAG>
        <VALUE>ArrayExpress</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>common name</TAG>
        <VALUE>human</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>interferon gamma release assay</TAG>
        <VALUE>positive</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>organism part</TAG>
        <VALUE>blood</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>preventative tuberculosis treatment</TAG>
        <VALUE>yes</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>progressor status (median follow-up 1.9 years)</TAG>
        <VALUE>non-progressor</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>progressor status (median follow-up 346 days)</TAG>
        <VALUE>non-progressor</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>roe et al 2019 subset (median follow-up 346 days)</TAG>
        <VALUE>yes</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sample name</TAG>
        <VALUE>E-MTAB-68451566551630:PR325_S9</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>scientific_name</TAG>
        <VALUE>Homo sapiens</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sex</TAG>
        <VALUE>male</VALUE>
      </SAMPLE_ATTRIBUTE>
    </SAMPLE_ATTRIBUTES>
  </SAMPLE>
  <SAMPLE alias="SAMEA5883839" accession="ERS3672295">
    <IDENTIFIERS>
      <PRIMARY_ID>ERS3672295</PRIMARY_ID>
      <EXTERNAL_ID namespace="BioSample">SAMEA5883839</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>PR311_S20</TITLE>
    <SAMPLE_NAME>
      <TAXON_ID>9606</TAXON_ID>
      <SCIENTIFIC_NAME>Homo sapiens</SCIENTIFIC_NAME>
    </SAMPLE_NAME>
    <DESCRIPTION>Protocols: Close contacts of patients with active tuberculosis (TB) were recruited from multiple TB clinics in London. At enrolment, peripheral blood RNA was collected into Tempus tubes. Total blood RNA was extracted using the Tempus Spin RNA Isolation Kit (Ambion; Life Technologies). Globin mRNA and genomic DNA were removed using the GlobinClear kit (Life Technologies) and the TURBO DNAfree kit (Ambion, Life Technologies), respectively. cDNA libraries were generated using the Kapa mRNA Hyperprep kit (Roche).</DESCRIPTION>
    <SAMPLE_ATTRIBUTES>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-FIRST-PUBLIC</TAG>
        <VALUE>2019-08-23T17:03:50Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-LAST-UPDATE</TAG>
        <VALUE>2019-08-23T10:24:58Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>External Id</TAG>
        <VALUE>SAMEA5883839</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC center name</TAG>
        <VALUE>UCL Infection&amp;Immunity Division</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC first public</TAG>
        <VALUE>2019-08-23T17:03:50Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC last update</TAG>
        <VALUE>2019-08-23T10:24:58Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC status</TAG>
        <VALUE>public</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>Submitter Id</TAG>
        <VALUE>E-MTAB-68451566551630:PR311_S20</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>age</TAG>
        <VALUE>25</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>broker name</TAG>
        <VALUE>ArrayExpress</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>common name</TAG>
        <VALUE>human</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>interferon gamma release assay</TAG>
        <VALUE>positive</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>organism part</TAG>
        <VALUE>blood</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>preventative tuberculosis treatment</TAG>
        <VALUE>yes</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>progressor status (median follow-up 1.9 years)</TAG>
        <VALUE>non-progressor</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>progressor status (median follow-up 346 days)</TAG>
        <VALUE>non-progressor</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>roe et al 2019 subset (median follow-up 346 days)</TAG>
        <VALUE>yes</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sample name</TAG>
        <VALUE>E-MTAB-68451566551630:PR311_S20</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>scientific_name</TAG>
        <VALUE>Homo sapiens</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sex</TAG>
        <VALUE>female</VALUE>
      </SAMPLE_ATTRIBUTE>
    </SAMPLE_ATTRIBUTES>
  </SAMPLE>
  <SAMPLE alias="SAMEA5883840" accession="ERS3672296">
    <IDENTIFIERS>
      <PRIMARY_ID>ERS3672296</PRIMARY_ID>
      <EXTERNAL_ID namespace="BioSample">SAMEA5883840</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>PR289_S24</TITLE>
    <SAMPLE_NAME>
      <TAXON_ID>9606</TAXON_ID>
      <SCIENTIFIC_NAME>Homo sapiens</SCIENTIFIC_NAME>
    </SAMPLE_NAME>
    <DESCRIPTION>Protocols: Close contacts of patients with active tuberculosis (TB) were recruited from multiple TB clinics in London. At enrolment, peripheral blood RNA was collected into Tempus tubes. Total blood RNA was extracted using the Tempus Spin RNA Isolation Kit (Ambion; Life Technologies). Globin mRNA and genomic DNA were removed using the GlobinClear kit (Life Technologies) and the TURBO DNAfree kit (Ambion, Life Technologies), respectively. cDNA libraries were generated using the Kapa mRNA Hyperprep kit (Roche).</DESCRIPTION>
    <SAMPLE_ATTRIBUTES>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-FIRST-PUBLIC</TAG>
        <VALUE>2019-08-23T17:03:50Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-LAST-UPDATE</TAG>
        <VALUE>2019-08-23T10:24:58Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>External Id</TAG>
        <VALUE>SAMEA5883840</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC center name</TAG>
        <VALUE>UCL Infection&amp;Immunity Division</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC first public</TAG>
        <VALUE>2019-08-23T17:03:50Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC last update</TAG>
        <VALUE>2019-08-23T10:24:58Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC status</TAG>
        <VALUE>public</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>Submitter Id</TAG>
        <VALUE>E-MTAB-68451566551630:PR289_S24</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>age</TAG>
        <VALUE>42</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>broker name</TAG>
        <VALUE>ArrayExpress</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>common name</TAG>
        <VALUE>human</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>interferon gamma release assay</TAG>
        <VALUE>positive</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>organism part</TAG>
        <VALUE>blood</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>preventative tuberculosis treatment</TAG>
        <VALUE>yes</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>progressor status (median follow-up 1.9 years)</TAG>
        <VALUE>non-progressor</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>progressor status (median follow-up 346 days)</TAG>
        <VALUE>non-progressor</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>roe et al 2019 subset (median follow-up 346 days)</TAG>
        <VALUE>yes</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sample name</TAG>
        <VALUE>E-MTAB-68451566551630:PR289_S24</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>scientific_name</TAG>
        <VALUE>Homo sapiens</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sex</TAG>
        <VALUE>male</VALUE>
      </SAMPLE_ATTRIBUTE>
    </SAMPLE_ATTRIBUTES>
  </SAMPLE>
  <SAMPLE alias="SAMEA5883841" accession="ERS3672297">
    <IDENTIFIERS>
      <PRIMARY_ID>ERS3672297</PRIMARY_ID>
      <EXTERNAL_ID namespace="BioSample">SAMEA5883841</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>PR335_S13</TITLE>
    <SAMPLE_NAME>
      <TAXON_ID>9606</TAXON_ID>
      <SCIENTIFIC_NAME>Homo sapiens</SCIENTIFIC_NAME>
    </SAMPLE_NAME>
    <DESCRIPTION>Protocols: Close contacts of patients with active tuberculosis (TB) were recruited from multiple TB clinics in London. At enrolment, peripheral blood RNA was collected into Tempus tubes. Total blood RNA was extracted using the Tempus Spin RNA Isolation Kit (Ambion; Life Technologies). Globin mRNA and genomic DNA were removed using the GlobinClear kit (Life Technologies) and the TURBO DNAfree kit (Ambion, Life Technologies), respectively. cDNA libraries were generated using the Kapa mRNA Hyperprep kit (Roche).</DESCRIPTION>
    <SAMPLE_ATTRIBUTES>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-FIRST-PUBLIC</TAG>
        <VALUE>2019-08-23T17:03:50Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-LAST-UPDATE</TAG>
        <VALUE>2019-08-23T10:24:58Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>External Id</TAG>
        <VALUE>SAMEA5883841</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC center name</TAG>
        <VALUE>UCL Infection&amp;Immunity Division</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC first public</TAG>
        <VALUE>2019-08-23T17:03:50Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC last update</TAG>
        <VALUE>2019-08-23T10:24:58Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC status</TAG>
        <VALUE>public</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>Submitter Id</TAG>
        <VALUE>E-MTAB-68451566551630:PR335_S13</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>age</TAG>
        <VALUE>30</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>broker name</TAG>
        <VALUE>ArrayExpress</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>common name</TAG>
        <VALUE>human</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>interferon gamma release assay</TAG>
        <VALUE>positive</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>organism part</TAG>
        <VALUE>blood</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>preventative tuberculosis treatment</TAG>
        <VALUE>yes</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>progressor status (median follow-up 1.9 years)</TAG>
        <VALUE>non-progressor</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>progressor status (median follow-up 346 days)</TAG>
        <VALUE>non-progressor</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>roe et al 2019 subset (median follow-up 346 days)</TAG>
        <VALUE>yes</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sample name</TAG>
        <VALUE>E-MTAB-68451566551630:PR335_S13</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>scientific_name</TAG>
        <VALUE>Homo sapiens</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sex</TAG>
        <VALUE>female</VALUE>
      </SAMPLE_ATTRIBUTE>
    </SAMPLE_ATTRIBUTES>
  </SAMPLE>
  <SAMPLE alias="SAMEA5883842" accession="ERS3672298">
    <IDENTIFIERS>
      <PRIMARY_ID>ERS3672298</PRIMARY_ID>
      <EXTERNAL_ID namespace="BioSample">SAMEA5883842</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>PR141_S22</TITLE>
    <SAMPLE_NAME>
      <TAXON_ID>9606</TAXON_ID>
      <SCIENTIFIC_NAME>Homo sapiens</SCIENTIFIC_NAME>
    </SAMPLE_NAME>
    <DESCRIPTION>Protocols: Close contacts of patients with active tuberculosis (TB) were recruited from multiple TB clinics in London. At enrolment, peripheral blood RNA was collected into Tempus tubes. Total blood RNA was extracted using the Tempus Spin RNA Isolation Kit (Ambion; Life Technologies). Globin mRNA and genomic DNA were removed using the GlobinClear kit (Life Technologies) and the TURBO DNAfree kit (Ambion, Life Technologies), respectively. cDNA libraries were generated using the Kapa mRNA Hyperprep kit (Roche).</DESCRIPTION>
    <SAMPLE_ATTRIBUTES>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-FIRST-PUBLIC</TAG>
        <VALUE>2019-08-23T17:03:50Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-LAST-UPDATE</TAG>
        <VALUE>2019-08-23T10:24:58Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>External Id</TAG>
        <VALUE>SAMEA5883842</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC center name</TAG>
        <VALUE>UCL Infection&amp;Immunity Division</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC first public</TAG>
        <VALUE>2019-08-23T17:03:50Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC last update</TAG>
        <VALUE>2019-08-23T10:24:58Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC status</TAG>
        <VALUE>public</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>Submitter Id</TAG>
        <VALUE>E-MTAB-68451566551630:PR141_S22</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>age</TAG>
        <VALUE>24</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>broker name</TAG>
        <VALUE>ArrayExpress</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>common name</TAG>
        <VALUE>human</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>interferon gamma release assay</TAG>
        <VALUE>positive</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>organism part</TAG>
        <VALUE>blood</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>preventative tuberculosis treatment</TAG>
        <VALUE>yes</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>progressor status (median follow-up 1.9 years)</TAG>
        <VALUE>non-progressor</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>progressor status (median follow-up 346 days)</TAG>
        <VALUE>non-progressor</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>roe et al 2019 subset (median follow-up 346 days)</TAG>
        <VALUE>yes</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sample name</TAG>
        <VALUE>E-MTAB-68451566551630:PR141_S22</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>scientific_name</TAG>
        <VALUE>Homo sapiens</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sex</TAG>
        <VALUE>male</VALUE>
      </SAMPLE_ATTRIBUTE>
    </SAMPLE_ATTRIBUTES>
  </SAMPLE>
  <SAMPLE alias="SAMEA5883843" accession="ERS3672299">
    <IDENTIFIERS>
      <PRIMARY_ID>ERS3672299</PRIMARY_ID>
      <EXTERNAL_ID namespace="BioSample">SAMEA5883843</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>PR201_S6</TITLE>
    <SAMPLE_NAME>
      <TAXON_ID>9606</TAXON_ID>
      <SCIENTIFIC_NAME>Homo sapiens</SCIENTIFIC_NAME>
    </SAMPLE_NAME>
    <DESCRIPTION>Protocols: Close contacts of patients with active tuberculosis (TB) were recruited from multiple TB clinics in London. At enrolment, peripheral blood RNA was collected into Tempus tubes. Total blood RNA was extracted using the Tempus Spin RNA Isolation Kit (Ambion; Life Technologies). Globin mRNA and genomic DNA were removed using the GlobinClear kit (Life Technologies) and the TURBO DNAfree kit (Ambion, Life Technologies), respectively. cDNA libraries were generated using the Kapa mRNA Hyperprep kit (Roche).</DESCRIPTION>
    <SAMPLE_ATTRIBUTES>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-FIRST-PUBLIC</TAG>
        <VALUE>2019-08-23T17:03:50Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-LAST-UPDATE</TAG>
        <VALUE>2019-08-23T10:24:58Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>External Id</TAG>
        <VALUE>SAMEA5883843</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC center name</TAG>
        <VALUE>UCL Infection&amp;Immunity Division</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC first public</TAG>
        <VALUE>2019-08-23T17:03:50Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC last update</TAG>
        <VALUE>2019-08-23T10:24:58Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC status</TAG>
        <VALUE>public</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>Submitter Id</TAG>
        <VALUE>E-MTAB-68451566551630:PR201_S6</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>age</TAG>
        <VALUE>35</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>broker name</TAG>
        <VALUE>ArrayExpress</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>common name</TAG>
        <VALUE>human</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>interferon gamma release assay</TAG>
        <VALUE>positive</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>organism part</TAG>
        <VALUE>blood</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>preventative tuberculosis treatment</TAG>
        <VALUE>yes</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>progressor status (median follow-up 1.9 years)</TAG>
        <VALUE>non-progressor</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>progressor status (median follow-up 346 days)</TAG>
        <VALUE>non-progressor</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>roe et al 2019 subset (median follow-up 346 days)</TAG>
        <VALUE>yes</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sample name</TAG>
        <VALUE>E-MTAB-68451566551630:PR201_S6</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>scientific_name</TAG>
        <VALUE>Homo sapiens</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sex</TAG>
        <VALUE>male</VALUE>
      </SAMPLE_ATTRIBUTE>
    </SAMPLE_ATTRIBUTES>
  </SAMPLE>
  <SAMPLE alias="SAMEA5883844" accession="ERS3672300">
    <IDENTIFIERS>
      <PRIMARY_ID>ERS3672300</PRIMARY_ID>
      <EXTERNAL_ID namespace="BioSample">SAMEA5883844</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>PR180_S19</TITLE>
    <SAMPLE_NAME>
      <TAXON_ID>9606</TAXON_ID>
      <SCIENTIFIC_NAME>Homo sapiens</SCIENTIFIC_NAME>
    </SAMPLE_NAME>
    <DESCRIPTION>Protocols: Close contacts of patients with active tuberculosis (TB) were recruited from multiple TB clinics in London. At enrolment, peripheral blood RNA was collected into Tempus tubes. Total blood RNA was extracted using the Tempus Spin RNA Isolation Kit (Ambion; Life Technologies). Globin mRNA and genomic DNA were removed using the GlobinClear kit (Life Technologies) and the TURBO DNAfree kit (Ambion, Life Technologies), respectively. cDNA libraries were generated using the Kapa mRNA Hyperprep kit (Roche).</DESCRIPTION>
    <SAMPLE_ATTRIBUTES>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-FIRST-PUBLIC</TAG>
        <VALUE>2019-08-23T17:03:50Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-LAST-UPDATE</TAG>
        <VALUE>2019-08-23T10:24:58Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>External Id</TAG>
        <VALUE>SAMEA5883844</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC center name</TAG>
        <VALUE>UCL Infection&amp;Immunity Division</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC first public</TAG>
        <VALUE>2019-08-23T17:03:50Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC last update</TAG>
        <VALUE>2019-08-23T10:24:58Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC status</TAG>
        <VALUE>public</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>Submitter Id</TAG>
        <VALUE>E-MTAB-68451566551630:PR180_S19</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>age</TAG>
        <VALUE>49</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>broker name</TAG>
        <VALUE>ArrayExpress</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>common name</TAG>
        <VALUE>human</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>interferon gamma release assay</TAG>
        <VALUE>positive</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>organism part</TAG>
        <VALUE>blood</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>preventative tuberculosis treatment</TAG>
        <VALUE>yes</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>progressor status (median follow-up 1.9 years)</TAG>
        <VALUE>non-progressor</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>progressor status (median follow-up 346 days)</TAG>
        <VALUE>non-progressor</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>roe et al 2019 subset (median follow-up 346 days)</TAG>
        <VALUE>yes</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sample name</TAG>
        <VALUE>E-MTAB-68451566551630:PR180_S19</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>scientific_name</TAG>
        <VALUE>Homo sapiens</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sex</TAG>
        <VALUE>female</VALUE>
      </SAMPLE_ATTRIBUTE>
    </SAMPLE_ATTRIBUTES>
  </SAMPLE>
  <SAMPLE alias="SAMEA5883845" accession="ERS3672301">
    <IDENTIFIERS>
      <PRIMARY_ID>ERS3672301</PRIMARY_ID>
      <EXTERNAL_ID namespace="BioSample">SAMEA5883845</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>PR223_S18</TITLE>
    <SAMPLE_NAME>
      <TAXON_ID>9606</TAXON_ID>
      <SCIENTIFIC_NAME>Homo sapiens</SCIENTIFIC_NAME>
    </SAMPLE_NAME>
    <DESCRIPTION>Protocols: Close contacts of patients with active tuberculosis (TB) were recruited from multiple TB clinics in London. At enrolment, peripheral blood RNA was collected into Tempus tubes. Total blood RNA was extracted using the Tempus Spin RNA Isolation Kit (Ambion; Life Technologies). Globin mRNA and genomic DNA were removed using the GlobinClear kit (Life Technologies) and the TURBO DNAfree kit (Ambion, Life Technologies), respectively. cDNA libraries were generated using the Kapa mRNA Hyperprep kit (Roche).</DESCRIPTION>
    <SAMPLE_ATTRIBUTES>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-FIRST-PUBLIC</TAG>
        <VALUE>2019-08-23T17:03:50Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-LAST-UPDATE</TAG>
        <VALUE>2019-08-23T10:24:58Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>External Id</TAG>
        <VALUE>SAMEA5883845</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC center name</TAG>
        <VALUE>UCL Infection&amp;Immunity Division</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC first public</TAG>
        <VALUE>2019-08-23T17:03:50Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC last update</TAG>
        <VALUE>2019-08-23T10:24:58Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC status</TAG>
        <VALUE>public</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>Submitter Id</TAG>
        <VALUE>E-MTAB-68451566551630:PR223_S18</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>age</TAG>
        <VALUE>57</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>broker name</TAG>
        <VALUE>ArrayExpress</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>common name</TAG>
        <VALUE>human</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>interferon gamma release assay</TAG>
        <VALUE>positive</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>organism part</TAG>
        <VALUE>blood</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>preventative tuberculosis treatment</TAG>
        <VALUE>yes</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>progressor status (median follow-up 1.9 years)</TAG>
        <VALUE>non-progressor</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>progressor status (median follow-up 346 days)</TAG>
        <VALUE>non-progressor</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>roe et al 2019 subset (median follow-up 346 days)</TAG>
        <VALUE>yes</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sample name</TAG>
        <VALUE>E-MTAB-68451566551630:PR223_S18</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>scientific_name</TAG>
        <VALUE>Homo sapiens</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sex</TAG>
        <VALUE>male</VALUE>
      </SAMPLE_ATTRIBUTE>
    </SAMPLE_ATTRIBUTES>
  </SAMPLE>
  <SAMPLE alias="SAMEA5883846" accession="ERS3672302">
    <IDENTIFIERS>
      <PRIMARY_ID>ERS3672302</PRIMARY_ID>
      <EXTERNAL_ID namespace="BioSample">SAMEA5883846</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>PR240_S16</TITLE>
    <SAMPLE_NAME>
      <TAXON_ID>9606</TAXON_ID>
      <SCIENTIFIC_NAME>Homo sapiens</SCIENTIFIC_NAME>
    </SAMPLE_NAME>
    <DESCRIPTION>Protocols: Close contacts of patients with active tuberculosis (TB) were recruited from multiple TB clinics in London. At enrolment, peripheral blood RNA was collected into Tempus tubes. Total blood RNA was extracted using the Tempus Spin RNA Isolation Kit (Ambion; Life Technologies). Globin mRNA and genomic DNA were removed using the GlobinClear kit (Life Technologies) and the TURBO DNAfree kit (Ambion, Life Technologies), respectively. cDNA libraries were generated using the Kapa mRNA Hyperprep kit (Roche).</DESCRIPTION>
    <SAMPLE_ATTRIBUTES>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-FIRST-PUBLIC</TAG>
        <VALUE>2019-08-23T17:03:50Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-LAST-UPDATE</TAG>
        <VALUE>2019-08-23T10:24:58Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>External Id</TAG>
        <VALUE>SAMEA5883846</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC center name</TAG>
        <VALUE>UCL Infection&amp;Immunity Division</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC first public</TAG>
        <VALUE>2019-08-23T17:03:50Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC last update</TAG>
        <VALUE>2019-08-23T10:24:58Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC status</TAG>
        <VALUE>public</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>Submitter Id</TAG>
        <VALUE>E-MTAB-68451566551630:PR240_S16</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>age</TAG>
        <VALUE>30</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>broker name</TAG>
        <VALUE>ArrayExpress</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>common name</TAG>
        <VALUE>human</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>interferon gamma release assay</TAG>
        <VALUE>positive</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>organism part</TAG>
        <VALUE>blood</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>preventative tuberculosis treatment</TAG>
        <VALUE>yes</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>progressor status (median follow-up 1.9 years)</TAG>
        <VALUE>non-progressor</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>progressor status (median follow-up 346 days)</TAG>
        <VALUE>non-progressor</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>roe et al 2019 subset (median follow-up 346 days)</TAG>
        <VALUE>yes</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sample name</TAG>
        <VALUE>E-MTAB-68451566551630:PR240_S16</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>scientific_name</TAG>
        <VALUE>Homo sapiens</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sex</TAG>
        <VALUE>male</VALUE>
      </SAMPLE_ATTRIBUTE>
    </SAMPLE_ATTRIBUTES>
  </SAMPLE>
  <SAMPLE alias="SAMEA5883847" accession="ERS3672303">
    <IDENTIFIERS>
      <PRIMARY_ID>ERS3672303</PRIMARY_ID>
      <EXTERNAL_ID namespace="BioSample">SAMEA5883847</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>PR248_0_S14</TITLE>
    <SAMPLE_NAME>
      <TAXON_ID>9606</TAXON_ID>
      <SCIENTIFIC_NAME>Homo sapiens</SCIENTIFIC_NAME>
    </SAMPLE_NAME>
    <DESCRIPTION>Protocols: Close contacts of patients with active tuberculosis (TB) were recruited from multiple TB clinics in London. At enrolment, peripheral blood RNA was collected into Tempus tubes. Total blood RNA was extracted using the Tempus Spin RNA Isolation Kit (Ambion; Life Technologies). Globin mRNA and genomic DNA were removed using the GlobinClear kit (Life Technologies) and the TURBO DNAfree kit (Ambion, Life Technologies), respectively. cDNA libraries were generated using the Kapa mRNA Hyperprep kit (Roche).</DESCRIPTION>
    <SAMPLE_ATTRIBUTES>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-FIRST-PUBLIC</TAG>
        <VALUE>2019-08-23T17:03:50Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-LAST-UPDATE</TAG>
        <VALUE>2019-08-23T10:24:58Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>External Id</TAG>
        <VALUE>SAMEA5883847</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC center name</TAG>
        <VALUE>UCL Infection&amp;Immunity Division</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC first public</TAG>
        <VALUE>2019-08-23T17:03:50Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC last update</TAG>
        <VALUE>2019-08-23T10:24:58Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC status</TAG>
        <VALUE>public</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>Submitter Id</TAG>
        <VALUE>E-MTAB-68451566551630:PR248_0_S14</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>age</TAG>
        <VALUE>27</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>broker name</TAG>
        <VALUE>ArrayExpress</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>common name</TAG>
        <VALUE>human</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>interferon gamma release assay</TAG>
        <VALUE>positive</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>organism part</TAG>
        <VALUE>blood</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>preventative tuberculosis treatment</TAG>
        <VALUE>yes</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>progressor status (median follow-up 1.9 years)</TAG>
        <VALUE>non-progressor</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>progressor status (median follow-up 346 days)</TAG>
        <VALUE>non-progressor</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>roe et al 2019 subset (median follow-up 346 days)</TAG>
        <VALUE>yes</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sample name</TAG>
        <VALUE>E-MTAB-68451566551630:PR248_0_S14</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>scientific_name</TAG>
        <VALUE>Homo sapiens</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sex</TAG>
        <VALUE>male</VALUE>
      </SAMPLE_ATTRIBUTE>
    </SAMPLE_ATTRIBUTES>
  </SAMPLE>
  <SAMPLE alias="SAMEA5883848" accession="ERS3672304">
    <IDENTIFIERS>
      <PRIMARY_ID>ERS3672304</PRIMARY_ID>
      <EXTERNAL_ID namespace="BioSample">SAMEA5883848</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>PR196_S18</TITLE>
    <SAMPLE_NAME>
      <TAXON_ID>9606</TAXON_ID>
      <SCIENTIFIC_NAME>Homo sapiens</SCIENTIFIC_NAME>
    </SAMPLE_NAME>
    <DESCRIPTION>Protocols: Close contacts of patients with active tuberculosis (TB) were recruited from multiple TB clinics in London. At enrolment, peripheral blood RNA was collected into Tempus tubes. Total blood RNA was extracted using the Tempus Spin RNA Isolation Kit (Ambion; Life Technologies). Globin mRNA and genomic DNA were removed using the GlobinClear kit (Life Technologies) and the TURBO DNAfree kit (Ambion, Life Technologies), respectively. cDNA libraries were generated using the Kapa mRNA Hyperprep kit (Roche).</DESCRIPTION>
    <SAMPLE_ATTRIBUTES>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-FIRST-PUBLIC</TAG>
        <VALUE>2019-08-23T17:03:50Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-LAST-UPDATE</TAG>
        <VALUE>2019-08-23T10:24:58Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>External Id</TAG>
        <VALUE>SAMEA5883848</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC center name</TAG>
        <VALUE>UCL Infection&amp;Immunity Division</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC first public</TAG>
        <VALUE>2019-08-23T17:03:50Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC last update</TAG>
        <VALUE>2019-08-23T10:24:58Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC status</TAG>
        <VALUE>public</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>Submitter Id</TAG>
        <VALUE>E-MTAB-68451566551630:PR196_S18</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>age</TAG>
        <VALUE>26</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>broker name</TAG>
        <VALUE>ArrayExpress</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>common name</TAG>
        <VALUE>human</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>interferon gamma release assay</TAG>
        <VALUE>positive</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>organism part</TAG>
        <VALUE>blood</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>preventative tuberculosis treatment</TAG>
        <VALUE>yes</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>progressor status (median follow-up 1.9 years)</TAG>
        <VALUE>non-progressor</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>progressor status (median follow-up 346 days)</TAG>
        <VALUE>non-progressor</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>roe et al 2019 subset (median follow-up 346 days)</TAG>
        <VALUE>yes</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sample name</TAG>
        <VALUE>E-MTAB-68451566551630:PR196_S18</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>scientific_name</TAG>
        <VALUE>Homo sapiens</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sex</TAG>
        <VALUE>male</VALUE>
      </SAMPLE_ATTRIBUTE>
    </SAMPLE_ATTRIBUTES>
  </SAMPLE>
  <SAMPLE alias="SAMEA5883849" accession="ERS3672305">
    <IDENTIFIERS>
      <PRIMARY_ID>ERS3672305</PRIMARY_ID>
      <EXTERNAL_ID namespace="BioSample">SAMEA5883849</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>PR210_0_S10</TITLE>
    <SAMPLE_NAME>
      <TAXON_ID>9606</TAXON_ID>
      <SCIENTIFIC_NAME>Homo sapiens</SCIENTIFIC_NAME>
    </SAMPLE_NAME>
    <DESCRIPTION>Protocols: Close contacts of patients with active tuberculosis (TB) were recruited from multiple TB clinics in London. At enrolment, peripheral blood RNA was collected into Tempus tubes. Total blood RNA was extracted using the Tempus Spin RNA Isolation Kit (Ambion; Life Technologies). Globin mRNA and genomic DNA were removed using the GlobinClear kit (Life Technologies) and the TURBO DNAfree kit (Ambion, Life Technologies), respectively. cDNA libraries were generated using the Kapa mRNA Hyperprep kit (Roche).</DESCRIPTION>
    <SAMPLE_ATTRIBUTES>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-FIRST-PUBLIC</TAG>
        <VALUE>2019-08-23T17:03:50Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-LAST-UPDATE</TAG>
        <VALUE>2019-08-23T10:24:58Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>External Id</TAG>
        <VALUE>SAMEA5883849</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC center name</TAG>
        <VALUE>UCL Infection&amp;Immunity Division</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC first public</TAG>
        <VALUE>2019-08-23T17:03:50Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC last update</TAG>
        <VALUE>2019-08-23T10:24:58Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC status</TAG>
        <VALUE>public</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>Submitter Id</TAG>
        <VALUE>E-MTAB-68451566551630:PR210_0_S10</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>age</TAG>
        <VALUE>39</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>broker name</TAG>
        <VALUE>ArrayExpress</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>common name</TAG>
        <VALUE>human</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>interferon gamma release assay</TAG>
        <VALUE>positive</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>organism part</TAG>
        <VALUE>blood</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>preventative tuberculosis treatment</TAG>
        <VALUE>yes</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>progressor status (median follow-up 1.9 years)</TAG>
        <VALUE>non-progressor</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>progressor status (median follow-up 346 days)</TAG>
        <VALUE>non-progressor</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>roe et al 2019 subset (median follow-up 346 days)</TAG>
        <VALUE>yes</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sample name</TAG>
        <VALUE>E-MTAB-68451566551630:PR210_0_S10</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>scientific_name</TAG>
        <VALUE>Homo sapiens</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sex</TAG>
        <VALUE>male</VALUE>
      </SAMPLE_ATTRIBUTE>
    </SAMPLE_ATTRIBUTES>
  </SAMPLE>
  <SAMPLE alias="SAMEA5883850" accession="ERS3672306">
    <IDENTIFIERS>
      <PRIMARY_ID>ERS3672306</PRIMARY_ID>
      <EXTERNAL_ID namespace="BioSample">SAMEA5883850</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>PR211_0_S5</TITLE>
    <SAMPLE_NAME>
      <TAXON_ID>9606</TAXON_ID>
      <SCIENTIFIC_NAME>Homo sapiens</SCIENTIFIC_NAME>
    </SAMPLE_NAME>
    <DESCRIPTION>Protocols: Close contacts of patients with active tuberculosis (TB) were recruited from multiple TB clinics in London. At enrolment, peripheral blood RNA was collected into Tempus tubes. Total blood RNA was extracted using the Tempus Spin RNA Isolation Kit (Ambion; Life Technologies). Globin mRNA and genomic DNA were removed using the GlobinClear kit (Life Technologies) and the TURBO DNAfree kit (Ambion, Life Technologies), respectively. cDNA libraries were generated using the Kapa mRNA Hyperprep kit (Roche).</DESCRIPTION>
    <SAMPLE_ATTRIBUTES>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-FIRST-PUBLIC</TAG>
        <VALUE>2019-08-23T17:03:50Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-LAST-UPDATE</TAG>
        <VALUE>2019-08-23T10:24:58Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>External Id</TAG>
        <VALUE>SAMEA5883850</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC center name</TAG>
        <VALUE>UCL Infection&amp;Immunity Division</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC first public</TAG>
        <VALUE>2019-08-23T17:03:50Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC last update</TAG>
        <VALUE>2019-08-23T10:24:58Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC status</TAG>
        <VALUE>public</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>Submitter Id</TAG>
        <VALUE>E-MTAB-68451566551630:PR211_0_S5</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>age</TAG>
        <VALUE>46</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>broker name</TAG>
        <VALUE>ArrayExpress</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>common name</TAG>
        <VALUE>human</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>interferon gamma release assay</TAG>
        <VALUE>positive</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>organism part</TAG>
        <VALUE>blood</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>preventative tuberculosis treatment</TAG>
        <VALUE>yes</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>progressor status (median follow-up 1.9 years)</TAG>
        <VALUE>non-progressor</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>progressor status (median follow-up 346 days)</TAG>
        <VALUE>non-progressor</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>roe et al 2019 subset (median follow-up 346 days)</TAG>
        <VALUE>yes</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sample name</TAG>
        <VALUE>E-MTAB-68451566551630:PR211_0_S5</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>scientific_name</TAG>
        <VALUE>Homo sapiens</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sex</TAG>
        <VALUE>female</VALUE>
      </SAMPLE_ATTRIBUTE>
    </SAMPLE_ATTRIBUTES>
  </SAMPLE>
  <SAMPLE alias="SAMEA5883851" accession="ERS3672307">
    <IDENTIFIERS>
      <PRIMARY_ID>ERS3672307</PRIMARY_ID>
      <EXTERNAL_ID namespace="BioSample">SAMEA5883851</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>PR200_S9</TITLE>
    <SAMPLE_NAME>
      <TAXON_ID>9606</TAXON_ID>
      <SCIENTIFIC_NAME>Homo sapiens</SCIENTIFIC_NAME>
    </SAMPLE_NAME>
    <DESCRIPTION>Protocols: Close contacts of patients with active tuberculosis (TB) were recruited from multiple TB clinics in London. At enrolment, peripheral blood RNA was collected into Tempus tubes. Total blood RNA was extracted using the Tempus Spin RNA Isolation Kit (Ambion; Life Technologies). Globin mRNA and genomic DNA were removed using the GlobinClear kit (Life Technologies) and the TURBO DNAfree kit (Ambion, Life Technologies), respectively. cDNA libraries were generated using the Kapa mRNA Hyperprep kit (Roche).</DESCRIPTION>
    <SAMPLE_ATTRIBUTES>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-FIRST-PUBLIC</TAG>
        <VALUE>2019-08-23T17:03:50Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-LAST-UPDATE</TAG>
        <VALUE>2019-08-23T10:24:58Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>External Id</TAG>
        <VALUE>SAMEA5883851</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC center name</TAG>
        <VALUE>UCL Infection&amp;Immunity Division</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC first public</TAG>
        <VALUE>2019-08-23T17:03:50Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC last update</TAG>
        <VALUE>2019-08-23T10:24:58Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC status</TAG>
        <VALUE>public</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>Submitter Id</TAG>
        <VALUE>E-MTAB-68451566551630:PR200_S9</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>age</TAG>
        <VALUE>35</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>broker name</TAG>
        <VALUE>ArrayExpress</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>common name</TAG>
        <VALUE>human</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>interferon gamma release assay</TAG>
        <VALUE>positive</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>organism part</TAG>
        <VALUE>blood</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>preventative tuberculosis treatment</TAG>
        <VALUE>yes</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>progressor status (median follow-up 1.9 years)</TAG>
        <VALUE>non-progressor</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>progressor status (median follow-up 346 days)</TAG>
        <VALUE>non-progressor</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>roe et al 2019 subset (median follow-up 346 days)</TAG>
        <VALUE>yes</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sample name</TAG>
        <VALUE>E-MTAB-68451566551630:PR200_S9</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>scientific_name</TAG>
        <VALUE>Homo sapiens</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sex</TAG>
        <VALUE>male</VALUE>
      </SAMPLE_ATTRIBUTE>
    </SAMPLE_ATTRIBUTES>
  </SAMPLE>
  <SAMPLE alias="SAMEA5883852" accession="ERS3672308">
    <IDENTIFIERS>
      <PRIMARY_ID>ERS3672308</PRIMARY_ID>
      <EXTERNAL_ID namespace="BioSample">SAMEA5883852</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>PR016_S23</TITLE>
    <SAMPLE_NAME>
      <TAXON_ID>9606</TAXON_ID>
      <SCIENTIFIC_NAME>Homo sapiens</SCIENTIFIC_NAME>
    </SAMPLE_NAME>
    <DESCRIPTION>Protocols: Close contacts of patients with active tuberculosis (TB) were recruited from multiple TB clinics in London. At enrolment, peripheral blood RNA was collected into Tempus tubes. Total blood RNA was extracted using the Tempus Spin RNA Isolation Kit (Ambion; Life Technologies). Globin mRNA and genomic DNA were removed using the GlobinClear kit (Life Technologies) and the TURBO DNAfree kit (Ambion, Life Technologies), respectively. cDNA libraries were generated using the Kapa mRNA Hyperprep kit (Roche).</DESCRIPTION>
    <SAMPLE_ATTRIBUTES>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-FIRST-PUBLIC</TAG>
        <VALUE>2019-08-23T17:03:50Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-LAST-UPDATE</TAG>
        <VALUE>2019-08-23T10:24:58Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>External Id</TAG>
        <VALUE>SAMEA5883852</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC center name</TAG>
        <VALUE>UCL Infection&amp;Immunity Division</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC first public</TAG>
        <VALUE>2019-08-23T17:03:50Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC last update</TAG>
        <VALUE>2019-08-23T10:24:58Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC status</TAG>
        <VALUE>public</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>Submitter Id</TAG>
        <VALUE>E-MTAB-68451566551630:PR016_S23</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>age</TAG>
        <VALUE>28</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>broker name</TAG>
        <VALUE>ArrayExpress</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>common name</TAG>
        <VALUE>human</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>interferon gamma release assay</TAG>
        <VALUE>positive</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>organism part</TAG>
        <VALUE>blood</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>preventative tuberculosis treatment</TAG>
        <VALUE>yes</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>progressor status (median follow-up 1.9 years)</TAG>
        <VALUE>non-progressor</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>progressor status (median follow-up 346 days)</TAG>
        <VALUE>non-progressor</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>roe et al 2019 subset (median follow-up 346 days)</TAG>
        <VALUE>yes</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sample name</TAG>
        <VALUE>E-MTAB-68451566551630:PR016_S23</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>scientific_name</TAG>
        <VALUE>Homo sapiens</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sex</TAG>
        <VALUE>male</VALUE>
      </SAMPLE_ATTRIBUTE>
    </SAMPLE_ATTRIBUTES>
  </SAMPLE>
  <SAMPLE alias="SAMEA5883853" accession="ERS3672309">
    <IDENTIFIERS>
      <PRIMARY_ID>ERS3672309</PRIMARY_ID>
      <EXTERNAL_ID namespace="BioSample">SAMEA5883853</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>PR142_S12</TITLE>
    <SAMPLE_NAME>
      <TAXON_ID>9606</TAXON_ID>
      <SCIENTIFIC_NAME>Homo sapiens</SCIENTIFIC_NAME>
    </SAMPLE_NAME>
    <DESCRIPTION>Protocols: Close contacts of patients with active tuberculosis (TB) were recruited from multiple TB clinics in London. At enrolment, peripheral blood RNA was collected into Tempus tubes. Total blood RNA was extracted using the Tempus Spin RNA Isolation Kit (Ambion; Life Technologies). Globin mRNA and genomic DNA were removed using the GlobinClear kit (Life Technologies) and the TURBO DNAfree kit (Ambion, Life Technologies), respectively. cDNA libraries were generated using the Kapa mRNA Hyperprep kit (Roche).</DESCRIPTION>
    <SAMPLE_ATTRIBUTES>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-FIRST-PUBLIC</TAG>
        <VALUE>2019-08-23T17:03:50Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-LAST-UPDATE</TAG>
        <VALUE>2019-08-23T10:24:58Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>External Id</TAG>
        <VALUE>SAMEA5883853</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC center name</TAG>
        <VALUE>UCL Infection&amp;Immunity Division</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC first public</TAG>
        <VALUE>2019-08-23T17:03:50Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC last update</TAG>
        <VALUE>2019-08-23T10:24:58Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC status</TAG>
        <VALUE>public</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>Submitter Id</TAG>
        <VALUE>E-MTAB-68451566551630:PR142_S12</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>age</TAG>
        <VALUE>49</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>broker name</TAG>
        <VALUE>ArrayExpress</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>common name</TAG>
        <VALUE>human</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>interferon gamma release assay</TAG>
        <VALUE>negative</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>organism part</TAG>
        <VALUE>blood</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>preventative tuberculosis treatment</TAG>
        <VALUE>no</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>progressor status (median follow-up 1.9 years)</TAG>
        <VALUE>non-progressor</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>progressor status (median follow-up 346 days)</TAG>
        <VALUE>non-progressor</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>roe et al 2019 subset (median follow-up 346 days)</TAG>
        <VALUE>no</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sample name</TAG>
        <VALUE>E-MTAB-68451566551630:PR142_S12</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>scientific_name</TAG>
        <VALUE>Homo sapiens</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sex</TAG>
        <VALUE>female</VALUE>
      </SAMPLE_ATTRIBUTE>
    </SAMPLE_ATTRIBUTES>
  </SAMPLE>
  <SAMPLE alias="SAMEA5883854" accession="ERS3672310">
    <IDENTIFIERS>
      <PRIMARY_ID>ERS3672310</PRIMARY_ID>
      <EXTERNAL_ID namespace="BioSample">SAMEA5883854</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>PR132_S16</TITLE>
    <SAMPLE_NAME>
      <TAXON_ID>9606</TAXON_ID>
      <SCIENTIFIC_NAME>Homo sapiens</SCIENTIFIC_NAME>
    </SAMPLE_NAME>
    <DESCRIPTION>Protocols: Close contacts of patients with active tuberculosis (TB) were recruited from multiple TB clinics in London. At enrolment, peripheral blood RNA was collected into Tempus tubes. Total blood RNA was extracted using the Tempus Spin RNA Isolation Kit (Ambion; Life Technologies). Globin mRNA and genomic DNA were removed using the GlobinClear kit (Life Technologies) and the TURBO DNAfree kit (Ambion, Life Technologies), respectively. cDNA libraries were generated using the Kapa mRNA Hyperprep kit (Roche).</DESCRIPTION>
    <SAMPLE_ATTRIBUTES>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-FIRST-PUBLIC</TAG>
        <VALUE>2019-08-23T17:03:50Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-LAST-UPDATE</TAG>
        <VALUE>2019-08-23T10:24:58Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>External Id</TAG>
        <VALUE>SAMEA5883854</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC center name</TAG>
        <VALUE>UCL Infection&amp;Immunity Division</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC first public</TAG>
        <VALUE>2019-08-23T17:03:50Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC last update</TAG>
        <VALUE>2019-08-23T10:24:58Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC status</TAG>
        <VALUE>public</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>Submitter Id</TAG>
        <VALUE>E-MTAB-68451566551630:PR132_S16</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>age</TAG>
        <VALUE>30</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>broker name</TAG>
        <VALUE>ArrayExpress</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>common name</TAG>
        <VALUE>human</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>interferon gamma release assay</TAG>
        <VALUE>negative</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>organism part</TAG>
        <VALUE>blood</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>preventative tuberculosis treatment</TAG>
        <VALUE>no</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>progressor status (median follow-up 1.9 years)</TAG>
        <VALUE>non-progressor</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>progressor status (median follow-up 346 days)</TAG>
        <VALUE>non-progressor</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>roe et al 2019 subset (median follow-up 346 days)</TAG>
        <VALUE>no</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sample name</TAG>
        <VALUE>E-MTAB-68451566551630:PR132_S16</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>scientific_name</TAG>
        <VALUE>Homo sapiens</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sex</TAG>
        <VALUE>male</VALUE>
      </SAMPLE_ATTRIBUTE>
    </SAMPLE_ATTRIBUTES>
  </SAMPLE>
  <SAMPLE alias="SAMEA5883855" accession="ERS3672311">
    <IDENTIFIERS>
      <PRIMARY_ID>ERS3672311</PRIMARY_ID>
      <EXTERNAL_ID namespace="BioSample">SAMEA5883855</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>PR229_S19</TITLE>
    <SAMPLE_NAME>
      <TAXON_ID>9606</TAXON_ID>
      <SCIENTIFIC_NAME>Homo sapiens</SCIENTIFIC_NAME>
    </SAMPLE_NAME>
    <DESCRIPTION>Protocols: Close contacts of patients with active tuberculosis (TB) were recruited from multiple TB clinics in London. At enrolment, peripheral blood RNA was collected into Tempus tubes. Total blood RNA was extracted using the Tempus Spin RNA Isolation Kit (Ambion; Life Technologies). Globin mRNA and genomic DNA were removed using the GlobinClear kit (Life Technologies) and the TURBO DNAfree kit (Ambion, Life Technologies), respectively. cDNA libraries were generated using the Kapa mRNA Hyperprep kit (Roche).</DESCRIPTION>
    <SAMPLE_ATTRIBUTES>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-FIRST-PUBLIC</TAG>
        <VALUE>2019-08-23T17:03:50Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-LAST-UPDATE</TAG>
        <VALUE>2019-08-23T10:24:58Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>External Id</TAG>
        <VALUE>SAMEA5883855</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC center name</TAG>
        <VALUE>UCL Infection&amp;Immunity Division</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC first public</TAG>
        <VALUE>2019-08-23T17:03:50Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC last update</TAG>
        <VALUE>2019-08-23T10:24:58Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC status</TAG>
        <VALUE>public</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>Submitter Id</TAG>
        <VALUE>E-MTAB-68451566551630:PR229_S19</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>age</TAG>
        <VALUE>31</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>broker name</TAG>
        <VALUE>ArrayExpress</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>common name</TAG>
        <VALUE>human</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>interferon gamma release assay</TAG>
        <VALUE>negative</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>organism part</TAG>
        <VALUE>blood</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>preventative tuberculosis treatment</TAG>
        <VALUE>no</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>progressor status (median follow-up 1.9 years)</TAG>
        <VALUE>non-progressor</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>progressor status (median follow-up 346 days)</TAG>
        <VALUE>non-progressor</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>roe et al 2019 subset (median follow-up 346 days)</TAG>
        <VALUE>no</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sample name</TAG>
        <VALUE>E-MTAB-68451566551630:PR229_S19</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>scientific_name</TAG>
        <VALUE>Homo sapiens</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sex</TAG>
        <VALUE>female</VALUE>
      </SAMPLE_ATTRIBUTE>
    </SAMPLE_ATTRIBUTES>
  </SAMPLE>
  <SAMPLE alias="SAMEA5883856" accession="ERS3672312">
    <IDENTIFIERS>
      <PRIMARY_ID>ERS3672312</PRIMARY_ID>
      <EXTERNAL_ID namespace="BioSample">SAMEA5883856</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>PR110_S10</TITLE>
    <SAMPLE_NAME>
      <TAXON_ID>9606</TAXON_ID>
      <SCIENTIFIC_NAME>Homo sapiens</SCIENTIFIC_NAME>
    </SAMPLE_NAME>
    <DESCRIPTION>Protocols: Close contacts of patients with active tuberculosis (TB) were recruited from multiple TB clinics in London. At enrolment, peripheral blood RNA was collected into Tempus tubes. Total blood RNA was extracted using the Tempus Spin RNA Isolation Kit (Ambion; Life Technologies). Globin mRNA and genomic DNA were removed using the GlobinClear kit (Life Technologies) and the TURBO DNAfree kit (Ambion, Life Technologies), respectively. cDNA libraries were generated using the Kapa mRNA Hyperprep kit (Roche).</DESCRIPTION>
    <SAMPLE_ATTRIBUTES>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-FIRST-PUBLIC</TAG>
        <VALUE>2019-08-23T17:03:50Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-LAST-UPDATE</TAG>
        <VALUE>2019-08-23T10:24:58Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>External Id</TAG>
        <VALUE>SAMEA5883856</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC center name</TAG>
        <VALUE>UCL Infection&amp;Immunity Division</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC first public</TAG>
        <VALUE>2019-08-23T17:03:50Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC last update</TAG>
        <VALUE>2019-08-23T10:24:58Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC status</TAG>
        <VALUE>public</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>Submitter Id</TAG>
        <VALUE>E-MTAB-68451566551630:PR110_S10</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>age</TAG>
        <VALUE>21</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>broker name</TAG>
        <VALUE>ArrayExpress</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>common name</TAG>
        <VALUE>human</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>interferon gamma release assay</TAG>
        <VALUE>negative</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>organism part</TAG>
        <VALUE>blood</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>preventative tuberculosis treatment</TAG>
        <VALUE>no</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>progressor status (median follow-up 1.9 years)</TAG>
        <VALUE>non-progressor</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>progressor status (median follow-up 346 days)</TAG>
        <VALUE>non-progressor</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>roe et al 2019 subset (median follow-up 346 days)</TAG>
        <VALUE>no</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sample name</TAG>
        <VALUE>E-MTAB-68451566551630:PR110_S10</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>scientific_name</TAG>
        <VALUE>Homo sapiens</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sex</TAG>
        <VALUE>male</VALUE>
      </SAMPLE_ATTRIBUTE>
    </SAMPLE_ATTRIBUTES>
  </SAMPLE>
  <SAMPLE alias="SAMEA5883857" accession="ERS3672313">
    <IDENTIFIERS>
      <PRIMARY_ID>ERS3672313</PRIMARY_ID>
      <EXTERNAL_ID namespace="BioSample">SAMEA5883857</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>PR145_S3</TITLE>
    <SAMPLE_NAME>
      <TAXON_ID>9606</TAXON_ID>
      <SCIENTIFIC_NAME>Homo sapiens</SCIENTIFIC_NAME>
    </SAMPLE_NAME>
    <DESCRIPTION>Protocols: Close contacts of patients with active tuberculosis (TB) were recruited from multiple TB clinics in London. At enrolment, peripheral blood RNA was collected into Tempus tubes. Total blood RNA was extracted using the Tempus Spin RNA Isolation Kit (Ambion; Life Technologies). Globin mRNA and genomic DNA were removed using the GlobinClear kit (Life Technologies) and the TURBO DNAfree kit (Ambion, Life Technologies), respectively. cDNA libraries were generated using the Kapa mRNA Hyperprep kit (Roche).</DESCRIPTION>
    <SAMPLE_ATTRIBUTES>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-FIRST-PUBLIC</TAG>
        <VALUE>2019-08-23T17:03:50Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-LAST-UPDATE</TAG>
        <VALUE>2019-08-23T10:24:58Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>External Id</TAG>
        <VALUE>SAMEA5883857</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC center name</TAG>
        <VALUE>UCL Infection&amp;Immunity Division</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC first public</TAG>
        <VALUE>2019-08-23T17:03:50Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC last update</TAG>
        <VALUE>2019-08-23T10:24:58Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC status</TAG>
        <VALUE>public</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>Submitter Id</TAG>
        <VALUE>E-MTAB-68451566551630:PR145_S3</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>age</TAG>
        <VALUE>18</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>broker name</TAG>
        <VALUE>ArrayExpress</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>common name</TAG>
        <VALUE>human</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>interferon gamma release assay</TAG>
        <VALUE>negative</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>organism part</TAG>
        <VALUE>blood</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>preventative tuberculosis treatment</TAG>
        <VALUE>no</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>progressor status (median follow-up 1.9 years)</TAG>
        <VALUE>non-progressor</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>progressor status (median follow-up 346 days)</TAG>
        <VALUE>non-progressor</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>roe et al 2019 subset (median follow-up 346 days)</TAG>
        <VALUE>no</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sample name</TAG>
        <VALUE>E-MTAB-68451566551630:PR145_S3</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>scientific_name</TAG>
        <VALUE>Homo sapiens</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sex</TAG>
        <VALUE>male</VALUE>
      </SAMPLE_ATTRIBUTE>
    </SAMPLE_ATTRIBUTES>
  </SAMPLE>
  <SAMPLE alias="SAMEA5883858" accession="ERS3672314">
    <IDENTIFIERS>
      <PRIMARY_ID>ERS3672314</PRIMARY_ID>
      <EXTERNAL_ID namespace="BioSample">SAMEA5883858</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>PR055_S8</TITLE>
    <SAMPLE_NAME>
      <TAXON_ID>9606</TAXON_ID>
      <SCIENTIFIC_NAME>Homo sapiens</SCIENTIFIC_NAME>
    </SAMPLE_NAME>
    <DESCRIPTION>Protocols: Close contacts of patients with active tuberculosis (TB) were recruited from multiple TB clinics in London. At enrolment, peripheral blood RNA was collected into Tempus tubes. Total blood RNA was extracted using the Tempus Spin RNA Isolation Kit (Ambion; Life Technologies). Globin mRNA and genomic DNA were removed using the GlobinClear kit (Life Technologies) and the TURBO DNAfree kit (Ambion, Life Technologies), respectively. cDNA libraries were generated using the Kapa mRNA Hyperprep kit (Roche).</DESCRIPTION>
    <SAMPLE_ATTRIBUTES>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-FIRST-PUBLIC</TAG>
        <VALUE>2019-08-23T17:03:50Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-LAST-UPDATE</TAG>
        <VALUE>2019-08-23T10:24:58Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>External Id</TAG>
        <VALUE>SAMEA5883858</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC center name</TAG>
        <VALUE>UCL Infection&amp;Immunity Division</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC first public</TAG>
        <VALUE>2019-08-23T17:03:50Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC last update</TAG>
        <VALUE>2019-08-23T10:24:58Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC status</TAG>
        <VALUE>public</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>Submitter Id</TAG>
        <VALUE>E-MTAB-68451566551630:PR055_S8</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>age</TAG>
        <VALUE>19</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>broker name</TAG>
        <VALUE>ArrayExpress</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>common name</TAG>
        <VALUE>human</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>interferon gamma release assay</TAG>
        <VALUE>negative</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>organism part</TAG>
        <VALUE>blood</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>preventative tuberculosis treatment</TAG>
        <VALUE>no</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>progressor status (median follow-up 1.9 years)</TAG>
        <VALUE>non-progressor</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>progressor status (median follow-up 346 days)</TAG>
        <VALUE>non-progressor</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>roe et al 2019 subset (median follow-up 346 days)</TAG>
        <VALUE>no</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sample name</TAG>
        <VALUE>E-MTAB-68451566551630:PR055_S8</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>scientific_name</TAG>
        <VALUE>Homo sapiens</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sex</TAG>
        <VALUE>male</VALUE>
      </SAMPLE_ATTRIBUTE>
    </SAMPLE_ATTRIBUTES>
  </SAMPLE>
  <SAMPLE alias="SAMEA5883859" accession="ERS3672315">
    <IDENTIFIERS>
      <PRIMARY_ID>ERS3672315</PRIMARY_ID>
      <EXTERNAL_ID namespace="BioSample">SAMEA5883859</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>PR237_S21</TITLE>
    <SAMPLE_NAME>
      <TAXON_ID>9606</TAXON_ID>
      <SCIENTIFIC_NAME>Homo sapiens</SCIENTIFIC_NAME>
    </SAMPLE_NAME>
    <DESCRIPTION>Protocols: Close contacts of patients with active tuberculosis (TB) were recruited from multiple TB clinics in London. At enrolment, peripheral blood RNA was collected into Tempus tubes. Total blood RNA was extracted using the Tempus Spin RNA Isolation Kit (Ambion; Life Technologies). Globin mRNA and genomic DNA were removed using the GlobinClear kit (Life Technologies) and the TURBO DNAfree kit (Ambion, Life Technologies), respectively. cDNA libraries were generated using the Kapa mRNA Hyperprep kit (Roche).</DESCRIPTION>
    <SAMPLE_ATTRIBUTES>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-FIRST-PUBLIC</TAG>
        <VALUE>2019-08-23T17:03:50Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-LAST-UPDATE</TAG>
        <VALUE>2019-08-23T10:24:59Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>External Id</TAG>
        <VALUE>SAMEA5883859</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC center name</TAG>
        <VALUE>UCL Infection&amp;Immunity Division</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC first public</TAG>
        <VALUE>2019-08-23T17:03:50Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC last update</TAG>
        <VALUE>2019-08-23T10:24:59Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC status</TAG>
        <VALUE>public</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>Submitter Id</TAG>
        <VALUE>E-MTAB-68451566551630:PR237_S21</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>age</TAG>
        <VALUE>20</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>broker name</TAG>
        <VALUE>ArrayExpress</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>common name</TAG>
        <VALUE>human</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>interferon gamma release assay</TAG>
        <VALUE>negative</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>organism part</TAG>
        <VALUE>blood</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>preventative tuberculosis treatment</TAG>
        <VALUE>no</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>progressor status (median follow-up 1.9 years)</TAG>
        <VALUE>non-progressor</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>progressor status (median follow-up 346 days)</TAG>
        <VALUE>non-progressor</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>roe et al 2019 subset (median follow-up 346 days)</TAG>
        <VALUE>no</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sample name</TAG>
        <VALUE>E-MTAB-68451566551630:PR237_S21</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>scientific_name</TAG>
        <VALUE>Homo sapiens</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sex</TAG>
        <VALUE>male</VALUE>
      </SAMPLE_ATTRIBUTE>
    </SAMPLE_ATTRIBUTES>
  </SAMPLE>
  <SAMPLE alias="SAMEA5883860" accession="ERS3672316">
    <IDENTIFIERS>
      <PRIMARY_ID>ERS3672316</PRIMARY_ID>
      <EXTERNAL_ID namespace="BioSample">SAMEA5883860</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>PR138_S14</TITLE>
    <SAMPLE_NAME>
      <TAXON_ID>9606</TAXON_ID>
      <SCIENTIFIC_NAME>Homo sapiens</SCIENTIFIC_NAME>
    </SAMPLE_NAME>
    <DESCRIPTION>Protocols: Close contacts of patients with active tuberculosis (TB) were recruited from multiple TB clinics in London. At enrolment, peripheral blood RNA was collected into Tempus tubes. Total blood RNA was extracted using the Tempus Spin RNA Isolation Kit (Ambion; Life Technologies). Globin mRNA and genomic DNA were removed using the GlobinClear kit (Life Technologies) and the TURBO DNAfree kit (Ambion, Life Technologies), respectively. cDNA libraries were generated using the Kapa mRNA Hyperprep kit (Roche).</DESCRIPTION>
    <SAMPLE_ATTRIBUTES>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-FIRST-PUBLIC</TAG>
        <VALUE>2019-08-23T17:03:50Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-LAST-UPDATE</TAG>
        <VALUE>2019-08-23T10:24:59Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>External Id</TAG>
        <VALUE>SAMEA5883860</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC center name</TAG>
        <VALUE>UCL Infection&amp;Immunity Division</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC first public</TAG>
        <VALUE>2019-08-23T17:03:50Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC last update</TAG>
        <VALUE>2019-08-23T10:24:59Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC status</TAG>
        <VALUE>public</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>Submitter Id</TAG>
        <VALUE>E-MTAB-68451566551630:PR138_S14</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>age</TAG>
        <VALUE>44</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>broker name</TAG>
        <VALUE>ArrayExpress</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>common name</TAG>
        <VALUE>human</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>interferon gamma release assay</TAG>
        <VALUE>negative</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>organism part</TAG>
        <VALUE>blood</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>preventative tuberculosis treatment</TAG>
        <VALUE>no</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>progressor status (median follow-up 1.9 years)</TAG>
        <VALUE>non-progressor</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>progressor status (median follow-up 346 days)</TAG>
        <VALUE>non-progressor</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>roe et al 2019 subset (median follow-up 346 days)</TAG>
        <VALUE>no</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sample name</TAG>
        <VALUE>E-MTAB-68451566551630:PR138_S14</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>scientific_name</TAG>
        <VALUE>Homo sapiens</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sex</TAG>
        <VALUE>male</VALUE>
      </SAMPLE_ATTRIBUTE>
    </SAMPLE_ATTRIBUTES>
  </SAMPLE>
  <SAMPLE alias="SAMEA5883861" accession="ERS3672317">
    <IDENTIFIERS>
      <PRIMARY_ID>ERS3672317</PRIMARY_ID>
      <EXTERNAL_ID namespace="BioSample">SAMEA5883861</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>PR074_S9</TITLE>
    <SAMPLE_NAME>
      <TAXON_ID>9606</TAXON_ID>
      <SCIENTIFIC_NAME>Homo sapiens</SCIENTIFIC_NAME>
    </SAMPLE_NAME>
    <DESCRIPTION>Protocols: Close contacts of patients with active tuberculosis (TB) were recruited from multiple TB clinics in London. At enrolment, peripheral blood RNA was collected into Tempus tubes. Total blood RNA was extracted using the Tempus Spin RNA Isolation Kit (Ambion; Life Technologies). Globin mRNA and genomic DNA were removed using the GlobinClear kit (Life Technologies) and the TURBO DNAfree kit (Ambion, Life Technologies), respectively. cDNA libraries were generated using the Kapa mRNA Hyperprep kit (Roche).</DESCRIPTION>
    <SAMPLE_ATTRIBUTES>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-FIRST-PUBLIC</TAG>
        <VALUE>2019-08-23T17:03:50Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-LAST-UPDATE</TAG>
        <VALUE>2019-08-23T10:24:59Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>External Id</TAG>
        <VALUE>SAMEA5883861</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC center name</TAG>
        <VALUE>UCL Infection&amp;Immunity Division</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC first public</TAG>
        <VALUE>2019-08-23T17:03:50Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC last update</TAG>
        <VALUE>2019-08-23T10:24:59Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC status</TAG>
        <VALUE>public</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>Submitter Id</TAG>
        <VALUE>E-MTAB-68451566551630:PR074_S9</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>age</TAG>
        <VALUE>35</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>broker name</TAG>
        <VALUE>ArrayExpress</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>common name</TAG>
        <VALUE>human</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>interferon gamma release assay</TAG>
        <VALUE>negative</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>organism part</TAG>
        <VALUE>blood</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>preventative tuberculosis treatment</TAG>
        <VALUE>no</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>progressor status (median follow-up 1.9 years)</TAG>
        <VALUE>non-progressor</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>progressor status (median follow-up 346 days)</TAG>
        <VALUE>non-progressor</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>roe et al 2019 subset (median follow-up 346 days)</TAG>
        <VALUE>no</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sample name</TAG>
        <VALUE>E-MTAB-68451566551630:PR074_S9</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>scientific_name</TAG>
        <VALUE>Homo sapiens</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sex</TAG>
        <VALUE>male</VALUE>
      </SAMPLE_ATTRIBUTE>
    </SAMPLE_ATTRIBUTES>
  </SAMPLE>
  <SAMPLE alias="SAMEA5883862" accession="ERS3672318">
    <IDENTIFIERS>
      <PRIMARY_ID>ERS3672318</PRIMARY_ID>
      <EXTERNAL_ID namespace="BioSample">SAMEA5883862</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>PR148_S22</TITLE>
    <SAMPLE_NAME>
      <TAXON_ID>9606</TAXON_ID>
      <SCIENTIFIC_NAME>Homo sapiens</SCIENTIFIC_NAME>
    </SAMPLE_NAME>
    <DESCRIPTION>Protocols: Close contacts of patients with active tuberculosis (TB) were recruited from multiple TB clinics in London. At enrolment, peripheral blood RNA was collected into Tempus tubes. Total blood RNA was extracted using the Tempus Spin RNA Isolation Kit (Ambion; Life Technologies). Globin mRNA and genomic DNA were removed using the GlobinClear kit (Life Technologies) and the TURBO DNAfree kit (Ambion, Life Technologies), respectively. cDNA libraries were generated using the Kapa mRNA Hyperprep kit (Roche).</DESCRIPTION>
    <SAMPLE_ATTRIBUTES>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-FIRST-PUBLIC</TAG>
        <VALUE>2019-08-23T17:03:50Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-LAST-UPDATE</TAG>
        <VALUE>2019-08-23T10:24:59Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>External Id</TAG>
        <VALUE>SAMEA5883862</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC center name</TAG>
        <VALUE>UCL Infection&amp;Immunity Division</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC first public</TAG>
        <VALUE>2019-08-23T17:03:50Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC last update</TAG>
        <VALUE>2019-08-23T10:24:59Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC status</TAG>
        <VALUE>public</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>Submitter Id</TAG>
        <VALUE>E-MTAB-68451566551630:PR148_S22</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>age</TAG>
        <VALUE>47</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>broker name</TAG>
        <VALUE>ArrayExpress</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>common name</TAG>
        <VALUE>human</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>interferon gamma release assay</TAG>
        <VALUE>negative</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>organism part</TAG>
        <VALUE>blood</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>preventative tuberculosis treatment</TAG>
        <VALUE>no</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>progressor status (median follow-up 1.9 years)</TAG>
        <VALUE>non-progressor</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>progressor status (median follow-up 346 days)</TAG>
        <VALUE>non-progressor</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>roe et al 2019 subset (median follow-up 346 days)</TAG>
        <VALUE>no</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sample name</TAG>
        <VALUE>E-MTAB-68451566551630:PR148_S22</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>scientific_name</TAG>
        <VALUE>Homo sapiens</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sex</TAG>
        <VALUE>female</VALUE>
      </SAMPLE_ATTRIBUTE>
    </SAMPLE_ATTRIBUTES>
  </SAMPLE>
  <SAMPLE alias="SAMEA5883863" accession="ERS3672319">
    <IDENTIFIERS>
      <PRIMARY_ID>ERS3672319</PRIMARY_ID>
      <EXTERNAL_ID namespace="BioSample">SAMEA5883863</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>PR036_S13</TITLE>
    <SAMPLE_NAME>
      <TAXON_ID>9606</TAXON_ID>
      <SCIENTIFIC_NAME>Homo sapiens</SCIENTIFIC_NAME>
    </SAMPLE_NAME>
    <DESCRIPTION>Protocols: Close contacts of patients with active tuberculosis (TB) were recruited from multiple TB clinics in London. At enrolment, peripheral blood RNA was collected into Tempus tubes. Total blood RNA was extracted using the Tempus Spin RNA Isolation Kit (Ambion; Life Technologies). Globin mRNA and genomic DNA were removed using the GlobinClear kit (Life Technologies) and the TURBO DNAfree kit (Ambion, Life Technologies), respectively. cDNA libraries were generated using the Kapa mRNA Hyperprep kit (Roche).</DESCRIPTION>
    <SAMPLE_ATTRIBUTES>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-FIRST-PUBLIC</TAG>
        <VALUE>2019-08-23T17:03:50Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-LAST-UPDATE</TAG>
        <VALUE>2019-08-23T10:24:59Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>External Id</TAG>
        <VALUE>SAMEA5883863</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC center name</TAG>
        <VALUE>UCL Infection&amp;Immunity Division</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC first public</TAG>
        <VALUE>2019-08-23T17:03:50Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC last update</TAG>
        <VALUE>2019-08-23T10:24:59Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC status</TAG>
        <VALUE>public</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>Submitter Id</TAG>
        <VALUE>E-MTAB-68451566551630:PR036_S13</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>age</TAG>
        <VALUE>27</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>broker name</TAG>
        <VALUE>ArrayExpress</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>common name</TAG>
        <VALUE>human</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>interferon gamma release assay</TAG>
        <VALUE>negative</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>organism part</TAG>
        <VALUE>blood</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>preventative tuberculosis treatment</TAG>
        <VALUE>no</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>progressor status (median follow-up 1.9 years)</TAG>
        <VALUE>non-progressor</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>progressor status (median follow-up 346 days)</TAG>
        <VALUE>non-progressor</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>roe et al 2019 subset (median follow-up 346 days)</TAG>
        <VALUE>no</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sample name</TAG>
        <VALUE>E-MTAB-68451566551630:PR036_S13</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>scientific_name</TAG>
        <VALUE>Homo sapiens</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sex</TAG>
        <VALUE>female</VALUE>
      </SAMPLE_ATTRIBUTE>
    </SAMPLE_ATTRIBUTES>
  </SAMPLE>
  <SAMPLE alias="SAMEA5883864" accession="ERS3672320">
    <IDENTIFIERS>
      <PRIMARY_ID>ERS3672320</PRIMARY_ID>
      <EXTERNAL_ID namespace="BioSample">SAMEA5883864</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>PR104_S18</TITLE>
    <SAMPLE_NAME>
      <TAXON_ID>9606</TAXON_ID>
      <SCIENTIFIC_NAME>Homo sapiens</SCIENTIFIC_NAME>
    </SAMPLE_NAME>
    <DESCRIPTION>Protocols: Close contacts of patients with active tuberculosis (TB) were recruited from multiple TB clinics in London. At enrolment, peripheral blood RNA was collected into Tempus tubes. Total blood RNA was extracted using the Tempus Spin RNA Isolation Kit (Ambion; Life Technologies). Globin mRNA and genomic DNA were removed using the GlobinClear kit (Life Technologies) and the TURBO DNAfree kit (Ambion, Life Technologies), respectively. cDNA libraries were generated using the Kapa mRNA Hyperprep kit (Roche).</DESCRIPTION>
    <SAMPLE_ATTRIBUTES>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-FIRST-PUBLIC</TAG>
        <VALUE>2019-08-23T17:03:50Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-LAST-UPDATE</TAG>
        <VALUE>2019-08-23T10:24:59Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>External Id</TAG>
        <VALUE>SAMEA5883864</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC center name</TAG>
        <VALUE>UCL Infection&amp;Immunity Division</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC first public</TAG>
        <VALUE>2019-08-23T17:03:50Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC last update</TAG>
        <VALUE>2019-08-23T10:24:59Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC status</TAG>
        <VALUE>public</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>Submitter Id</TAG>
        <VALUE>E-MTAB-68451566551630:PR104_S18</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>age</TAG>
        <VALUE>42</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>broker name</TAG>
        <VALUE>ArrayExpress</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>common name</TAG>
        <VALUE>human</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>interferon gamma release assay</TAG>
        <VALUE>negative</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>organism part</TAG>
        <VALUE>blood</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>preventative tuberculosis treatment</TAG>
        <VALUE>no</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>progressor status (median follow-up 1.9 years)</TAG>
        <VALUE>non-progressor</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>progressor status (median follow-up 346 days)</TAG>
        <VALUE>non-progressor</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>roe et al 2019 subset (median follow-up 346 days)</TAG>
        <VALUE>no</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sample name</TAG>
        <VALUE>E-MTAB-68451566551630:PR104_S18</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>scientific_name</TAG>
        <VALUE>Homo sapiens</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sex</TAG>
        <VALUE>male</VALUE>
      </SAMPLE_ATTRIBUTE>
    </SAMPLE_ATTRIBUTES>
  </SAMPLE>
  <SAMPLE alias="SAMEA5883865" accession="ERS3672321">
    <IDENTIFIERS>
      <PRIMARY_ID>ERS3672321</PRIMARY_ID>
      <EXTERNAL_ID namespace="BioSample">SAMEA5883865</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>PR035_S1</TITLE>
    <SAMPLE_NAME>
      <TAXON_ID>9606</TAXON_ID>
      <SCIENTIFIC_NAME>Homo sapiens</SCIENTIFIC_NAME>
    </SAMPLE_NAME>
    <DESCRIPTION>Protocols: Close contacts of patients with active tuberculosis (TB) were recruited from multiple TB clinics in London. At enrolment, peripheral blood RNA was collected into Tempus tubes. Total blood RNA was extracted using the Tempus Spin RNA Isolation Kit (Ambion; Life Technologies). Globin mRNA and genomic DNA were removed using the GlobinClear kit (Life Technologies) and the TURBO DNAfree kit (Ambion, Life Technologies), respectively. cDNA libraries were generated using the Kapa mRNA Hyperprep kit (Roche).</DESCRIPTION>
    <SAMPLE_ATTRIBUTES>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-FIRST-PUBLIC</TAG>
        <VALUE>2019-08-23T17:03:50Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-LAST-UPDATE</TAG>
        <VALUE>2019-08-23T10:24:59Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>External Id</TAG>
        <VALUE>SAMEA5883865</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC center name</TAG>
        <VALUE>UCL Infection&amp;Immunity Division</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC first public</TAG>
        <VALUE>2019-08-23T17:03:50Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC last update</TAG>
        <VALUE>2019-08-23T10:24:59Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC status</TAG>
        <VALUE>public</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>Submitter Id</TAG>
        <VALUE>E-MTAB-68451566551630:PR035_S1</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>age</TAG>
        <VALUE>27</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>broker name</TAG>
        <VALUE>ArrayExpress</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>common name</TAG>
        <VALUE>human</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>interferon gamma release assay</TAG>
        <VALUE>negative</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>organism part</TAG>
        <VALUE>blood</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>preventative tuberculosis treatment</TAG>
        <VALUE>no</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>progressor status (median follow-up 1.9 years)</TAG>
        <VALUE>non-progressor</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>progressor status (median follow-up 346 days)</TAG>
        <VALUE>non-progressor</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>roe et al 2019 subset (median follow-up 346 days)</TAG>
        <VALUE>no</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sample name</TAG>
        <VALUE>E-MTAB-68451566551630:PR035_S1</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>scientific_name</TAG>
        <VALUE>Homo sapiens</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sex</TAG>
        <VALUE>female</VALUE>
      </SAMPLE_ATTRIBUTE>
    </SAMPLE_ATTRIBUTES>
  </SAMPLE>
  <SAMPLE alias="SAMEA5883866" accession="ERS3672322">
    <IDENTIFIERS>
      <PRIMARY_ID>ERS3672322</PRIMARY_ID>
      <EXTERNAL_ID namespace="BioSample">SAMEA5883866</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>PR152_S6</TITLE>
    <SAMPLE_NAME>
      <TAXON_ID>9606</TAXON_ID>
      <SCIENTIFIC_NAME>Homo sapiens</SCIENTIFIC_NAME>
    </SAMPLE_NAME>
    <DESCRIPTION>Protocols: Close contacts of patients with active tuberculosis (TB) were recruited from multiple TB clinics in London. At enrolment, peripheral blood RNA was collected into Tempus tubes. Total blood RNA was extracted using the Tempus Spin RNA Isolation Kit (Ambion; Life Technologies). Globin mRNA and genomic DNA were removed using the GlobinClear kit (Life Technologies) and the TURBO DNAfree kit (Ambion, Life Technologies), respectively. cDNA libraries were generated using the Kapa mRNA Hyperprep kit (Roche).</DESCRIPTION>
    <SAMPLE_ATTRIBUTES>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-FIRST-PUBLIC</TAG>
        <VALUE>2019-08-23T17:03:50Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-LAST-UPDATE</TAG>
        <VALUE>2019-08-23T10:24:59Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>External Id</TAG>
        <VALUE>SAMEA5883866</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC center name</TAG>
        <VALUE>UCL Infection&amp;Immunity Division</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC first public</TAG>
        <VALUE>2019-08-23T17:03:50Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC last update</TAG>
        <VALUE>2019-08-23T10:24:59Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC status</TAG>
        <VALUE>public</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>Submitter Id</TAG>
        <VALUE>E-MTAB-68451566551630:PR152_S6</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>age</TAG>
        <VALUE>31</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>broker name</TAG>
        <VALUE>ArrayExpress</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>common name</TAG>
        <VALUE>human</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>interferon gamma release assay</TAG>
        <VALUE>negative</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>organism part</TAG>
        <VALUE>blood</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>preventative tuberculosis treatment</TAG>
        <VALUE>no</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>progressor status (median follow-up 1.9 years)</TAG>
        <VALUE>non-progressor</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>progressor status (median follow-up 346 days)</TAG>
        <VALUE>non-progressor</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>roe et al 2019 subset (median follow-up 346 days)</TAG>
        <VALUE>no</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sample name</TAG>
        <VALUE>E-MTAB-68451566551630:PR152_S6</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>scientific_name</TAG>
        <VALUE>Homo sapiens</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sex</TAG>
        <VALUE>female</VALUE>
      </SAMPLE_ATTRIBUTE>
    </SAMPLE_ATTRIBUTES>
  </SAMPLE>
  <SAMPLE alias="SAMEA5883867" accession="ERS3672323">
    <IDENTIFIERS>
      <PRIMARY_ID>ERS3672323</PRIMARY_ID>
      <EXTERNAL_ID namespace="BioSample">SAMEA5883867</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>PR245_S24</TITLE>
    <SAMPLE_NAME>
      <TAXON_ID>9606</TAXON_ID>
      <SCIENTIFIC_NAME>Homo sapiens</SCIENTIFIC_NAME>
    </SAMPLE_NAME>
    <DESCRIPTION>Protocols: Close contacts of patients with active tuberculosis (TB) were recruited from multiple TB clinics in London. At enrolment, peripheral blood RNA was collected into Tempus tubes. Total blood RNA was extracted using the Tempus Spin RNA Isolation Kit (Ambion; Life Technologies). Globin mRNA and genomic DNA were removed using the GlobinClear kit (Life Technologies) and the TURBO DNAfree kit (Ambion, Life Technologies), respectively. cDNA libraries were generated using the Kapa mRNA Hyperprep kit (Roche).</DESCRIPTION>
    <SAMPLE_ATTRIBUTES>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-FIRST-PUBLIC</TAG>
        <VALUE>2019-08-23T17:03:50Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-LAST-UPDATE</TAG>
        <VALUE>2019-08-23T10:24:59Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>External Id</TAG>
        <VALUE>SAMEA5883867</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC center name</TAG>
        <VALUE>UCL Infection&amp;Immunity Division</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC first public</TAG>
        <VALUE>2019-08-23T17:03:50Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC last update</TAG>
        <VALUE>2019-08-23T10:24:59Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC status</TAG>
        <VALUE>public</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>Submitter Id</TAG>
        <VALUE>E-MTAB-68451566551630:PR245_S24</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>age</TAG>
        <VALUE>34</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>broker name</TAG>
        <VALUE>ArrayExpress</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>common name</TAG>
        <VALUE>human</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>interferon gamma release assay</TAG>
        <VALUE>negative</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>organism part</TAG>
        <VALUE>blood</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>preventative tuberculosis treatment</TAG>
        <VALUE>no</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>progressor status (median follow-up 1.9 years)</TAG>
        <VALUE>non-progressor</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>progressor status (median follow-up 346 days)</TAG>
        <VALUE>non-progressor</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>roe et al 2019 subset (median follow-up 346 days)</TAG>
        <VALUE>no</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sample name</TAG>
        <VALUE>E-MTAB-68451566551630:PR245_S24</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>scientific_name</TAG>
        <VALUE>Homo sapiens</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sex</TAG>
        <VALUE>male</VALUE>
      </SAMPLE_ATTRIBUTE>
    </SAMPLE_ATTRIBUTES>
  </SAMPLE>
  <SAMPLE alias="SAMEA5883868" accession="ERS3672324">
    <IDENTIFIERS>
      <PRIMARY_ID>ERS3672324</PRIMARY_ID>
      <EXTERNAL_ID namespace="BioSample">SAMEA5883868</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>PR066_S4</TITLE>
    <SAMPLE_NAME>
      <TAXON_ID>9606</TAXON_ID>
      <SCIENTIFIC_NAME>Homo sapiens</SCIENTIFIC_NAME>
    </SAMPLE_NAME>
    <DESCRIPTION>Protocols: Close contacts of patients with active tuberculosis (TB) were recruited from multiple TB clinics in London. At enrolment, peripheral blood RNA was collected into Tempus tubes. Total blood RNA was extracted using the Tempus Spin RNA Isolation Kit (Ambion; Life Technologies). Globin mRNA and genomic DNA were removed using the GlobinClear kit (Life Technologies) and the TURBO DNAfree kit (Ambion, Life Technologies), respectively. cDNA libraries were generated using the Kapa mRNA Hyperprep kit (Roche).</DESCRIPTION>
    <SAMPLE_ATTRIBUTES>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-FIRST-PUBLIC</TAG>
        <VALUE>2019-08-23T17:03:50Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-LAST-UPDATE</TAG>
        <VALUE>2019-08-23T10:24:59Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>External Id</TAG>
        <VALUE>SAMEA5883868</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC center name</TAG>
        <VALUE>UCL Infection&amp;Immunity Division</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC first public</TAG>
        <VALUE>2019-08-23T17:03:50Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC last update</TAG>
        <VALUE>2019-08-23T10:24:59Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC status</TAG>
        <VALUE>public</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>Submitter Id</TAG>
        <VALUE>E-MTAB-68451566551630:PR066_S4</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>age</TAG>
        <VALUE>28</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>broker name</TAG>
        <VALUE>ArrayExpress</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>common name</TAG>
        <VALUE>human</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>interferon gamma release assay</TAG>
        <VALUE>negative</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>organism part</TAG>
        <VALUE>blood</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>preventative tuberculosis treatment</TAG>
        <VALUE>no</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>progressor status (median follow-up 1.9 years)</TAG>
        <VALUE>non-progressor</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>progressor status (median follow-up 346 days)</TAG>
        <VALUE>non-progressor</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>roe et al 2019 subset (median follow-up 346 days)</TAG>
        <VALUE>no</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sample name</TAG>
        <VALUE>E-MTAB-68451566551630:PR066_S4</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>scientific_name</TAG>
        <VALUE>Homo sapiens</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sex</TAG>
        <VALUE>female</VALUE>
      </SAMPLE_ATTRIBUTE>
    </SAMPLE_ATTRIBUTES>
  </SAMPLE>
  <SAMPLE alias="SAMEA5883869" accession="ERS3672325">
    <IDENTIFIERS>
      <PRIMARY_ID>ERS3672325</PRIMARY_ID>
      <EXTERNAL_ID namespace="BioSample">SAMEA5883869</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>PR087_S7</TITLE>
    <SAMPLE_NAME>
      <TAXON_ID>9606</TAXON_ID>
      <SCIENTIFIC_NAME>Homo sapiens</SCIENTIFIC_NAME>
    </SAMPLE_NAME>
    <DESCRIPTION>Protocols: Close contacts of patients with active tuberculosis (TB) were recruited from multiple TB clinics in London. At enrolment, peripheral blood RNA was collected into Tempus tubes. Total blood RNA was extracted using the Tempus Spin RNA Isolation Kit (Ambion; Life Technologies). Globin mRNA and genomic DNA were removed using the GlobinClear kit (Life Technologies) and the TURBO DNAfree kit (Ambion, Life Technologies), respectively. cDNA libraries were generated using the Kapa mRNA Hyperprep kit (Roche).</DESCRIPTION>
    <SAMPLE_ATTRIBUTES>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-FIRST-PUBLIC</TAG>
        <VALUE>2019-08-23T17:03:50Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-LAST-UPDATE</TAG>
        <VALUE>2019-08-23T10:24:59Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>External Id</TAG>
        <VALUE>SAMEA5883869</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC center name</TAG>
        <VALUE>UCL Infection&amp;Immunity Division</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC first public</TAG>
        <VALUE>2019-08-23T17:03:50Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC last update</TAG>
        <VALUE>2019-08-23T10:24:59Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC status</TAG>
        <VALUE>public</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>Submitter Id</TAG>
        <VALUE>E-MTAB-68451566551630:PR087_S7</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>age</TAG>
        <VALUE>24</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>broker name</TAG>
        <VALUE>ArrayExpress</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>common name</TAG>
        <VALUE>human</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>interferon gamma release assay</TAG>
        <VALUE>negative</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>organism part</TAG>
        <VALUE>blood</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>preventative tuberculosis treatment</TAG>
        <VALUE>no</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>progressor status (median follow-up 1.9 years)</TAG>
        <VALUE>non-progressor</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>progressor status (median follow-up 346 days)</TAG>
        <VALUE>non-progressor</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>roe et al 2019 subset (median follow-up 346 days)</TAG>
        <VALUE>no</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sample name</TAG>
        <VALUE>E-MTAB-68451566551630:PR087_S7</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>scientific_name</TAG>
        <VALUE>Homo sapiens</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sex</TAG>
        <VALUE>female</VALUE>
      </SAMPLE_ATTRIBUTE>
    </SAMPLE_ATTRIBUTES>
  </SAMPLE>
  <SAMPLE alias="SAMEA5883870" accession="ERS3672326">
    <IDENTIFIERS>
      <PRIMARY_ID>ERS3672326</PRIMARY_ID>
      <EXTERNAL_ID namespace="BioSample">SAMEA5883870</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>PR025_S5</TITLE>
    <SAMPLE_NAME>
      <TAXON_ID>9606</TAXON_ID>
      <SCIENTIFIC_NAME>Homo sapiens</SCIENTIFIC_NAME>
    </SAMPLE_NAME>
    <DESCRIPTION>Protocols: Close contacts of patients with active tuberculosis (TB) were recruited from multiple TB clinics in London. At enrolment, peripheral blood RNA was collected into Tempus tubes. Total blood RNA was extracted using the Tempus Spin RNA Isolation Kit (Ambion; Life Technologies). Globin mRNA and genomic DNA were removed using the GlobinClear kit (Life Technologies) and the TURBO DNAfree kit (Ambion, Life Technologies), respectively. cDNA libraries were generated using the Kapa mRNA Hyperprep kit (Roche).</DESCRIPTION>
    <SAMPLE_ATTRIBUTES>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-FIRST-PUBLIC</TAG>
        <VALUE>2019-08-23T17:03:50Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-LAST-UPDATE</TAG>
        <VALUE>2019-08-23T10:24:59Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>External Id</TAG>
        <VALUE>SAMEA5883870</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC center name</TAG>
        <VALUE>UCL Infection&amp;Immunity Division</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC first public</TAG>
        <VALUE>2019-08-23T17:03:50Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC last update</TAG>
        <VALUE>2019-08-23T10:24:59Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC status</TAG>
        <VALUE>public</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>Submitter Id</TAG>
        <VALUE>E-MTAB-68451566551630:PR025_S5</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>age</TAG>
        <VALUE>45</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>broker name</TAG>
        <VALUE>ArrayExpress</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>common name</TAG>
        <VALUE>human</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>interferon gamma release assay</TAG>
        <VALUE>negative</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>organism part</TAG>
        <VALUE>blood</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>preventative tuberculosis treatment</TAG>
        <VALUE>no</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>progressor status (median follow-up 1.9 years)</TAG>
        <VALUE>non-progressor</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>progressor status (median follow-up 346 days)</TAG>
        <VALUE>non-progressor</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>roe et al 2019 subset (median follow-up 346 days)</TAG>
        <VALUE>no</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sample name</TAG>
        <VALUE>E-MTAB-68451566551630:PR025_S5</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>scientific_name</TAG>
        <VALUE>Homo sapiens</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sex</TAG>
        <VALUE>female</VALUE>
      </SAMPLE_ATTRIBUTE>
    </SAMPLE_ATTRIBUTES>
  </SAMPLE>
  <SAMPLE alias="SAMEA5883871" accession="ERS3672327">
    <IDENTIFIERS>
      <PRIMARY_ID>ERS3672327</PRIMARY_ID>
      <EXTERNAL_ID namespace="BioSample">SAMEA5883871</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>PR050_S11</TITLE>
    <SAMPLE_NAME>
      <TAXON_ID>9606</TAXON_ID>
      <SCIENTIFIC_NAME>Homo sapiens</SCIENTIFIC_NAME>
    </SAMPLE_NAME>
    <DESCRIPTION>Protocols: Close contacts of patients with active tuberculosis (TB) were recruited from multiple TB clinics in London. At enrolment, peripheral blood RNA was collected into Tempus tubes. Total blood RNA was extracted using the Tempus Spin RNA Isolation Kit (Ambion; Life Technologies). Globin mRNA and genomic DNA were removed using the GlobinClear kit (Life Technologies) and the TURBO DNAfree kit (Ambion, Life Technologies), respectively. cDNA libraries were generated using the Kapa mRNA Hyperprep kit (Roche).</DESCRIPTION>
    <SAMPLE_ATTRIBUTES>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-FIRST-PUBLIC</TAG>
        <VALUE>2019-08-23T17:03:50Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-LAST-UPDATE</TAG>
        <VALUE>2019-08-23T10:24:59Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>External Id</TAG>
        <VALUE>SAMEA5883871</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC center name</TAG>
        <VALUE>UCL Infection&amp;Immunity Division</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC first public</TAG>
        <VALUE>2019-08-23T17:03:50Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC last update</TAG>
        <VALUE>2019-08-23T10:24:59Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC status</TAG>
        <VALUE>public</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>Submitter Id</TAG>
        <VALUE>E-MTAB-68451566551630:PR050_S11</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>age</TAG>
        <VALUE>26</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>broker name</TAG>
        <VALUE>ArrayExpress</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>common name</TAG>
        <VALUE>human</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>interferon gamma release assay</TAG>
        <VALUE>negative</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>organism part</TAG>
        <VALUE>blood</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>preventative tuberculosis treatment</TAG>
        <VALUE>no</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>progressor status (median follow-up 1.9 years)</TAG>
        <VALUE>non-progressor</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>progressor status (median follow-up 346 days)</TAG>
        <VALUE>non-progressor</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>roe et al 2019 subset (median follow-up 346 days)</TAG>
        <VALUE>no</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sample name</TAG>
        <VALUE>E-MTAB-68451566551630:PR050_S11</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>scientific_name</TAG>
        <VALUE>Homo sapiens</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sex</TAG>
        <VALUE>male</VALUE>
      </SAMPLE_ATTRIBUTE>
    </SAMPLE_ATTRIBUTES>
  </SAMPLE>
  <SAMPLE alias="SAMEA5883872" accession="ERS3672328">
    <IDENTIFIERS>
      <PRIMARY_ID>ERS3672328</PRIMARY_ID>
      <EXTERNAL_ID namespace="BioSample">SAMEA5883872</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>PR252_S23</TITLE>
    <SAMPLE_NAME>
      <TAXON_ID>9606</TAXON_ID>
      <SCIENTIFIC_NAME>Homo sapiens</SCIENTIFIC_NAME>
    </SAMPLE_NAME>
    <DESCRIPTION>Protocols: Close contacts of patients with active tuberculosis (TB) were recruited from multiple TB clinics in London. At enrolment, peripheral blood RNA was collected into Tempus tubes. Total blood RNA was extracted using the Tempus Spin RNA Isolation Kit (Ambion; Life Technologies). Globin mRNA and genomic DNA were removed using the GlobinClear kit (Life Technologies) and the TURBO DNAfree kit (Ambion, Life Technologies), respectively. cDNA libraries were generated using the Kapa mRNA Hyperprep kit (Roche).</DESCRIPTION>
    <SAMPLE_ATTRIBUTES>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-FIRST-PUBLIC</TAG>
        <VALUE>2019-08-23T17:03:50Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-LAST-UPDATE</TAG>
        <VALUE>2019-08-23T10:24:59Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>External Id</TAG>
        <VALUE>SAMEA5883872</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC center name</TAG>
        <VALUE>UCL Infection&amp;Immunity Division</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC first public</TAG>
        <VALUE>2019-08-23T17:03:50Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC last update</TAG>
        <VALUE>2019-08-23T10:24:59Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC status</TAG>
        <VALUE>public</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>Submitter Id</TAG>
        <VALUE>E-MTAB-68451566551630:PR252_S23</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>age</TAG>
        <VALUE>29</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>broker name</TAG>
        <VALUE>ArrayExpress</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>common name</TAG>
        <VALUE>human</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>interferon gamma release assay</TAG>
        <VALUE>negative</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>organism part</TAG>
        <VALUE>blood</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>preventative tuberculosis treatment</TAG>
        <VALUE>no</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>progressor status (median follow-up 1.9 years)</TAG>
        <VALUE>non-progressor</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>progressor status (median follow-up 346 days)</TAG>
        <VALUE>non-progressor</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>roe et al 2019 subset (median follow-up 346 days)</TAG>
        <VALUE>no</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sample name</TAG>
        <VALUE>E-MTAB-68451566551630:PR252_S23</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>scientific_name</TAG>
        <VALUE>Homo sapiens</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sex</TAG>
        <VALUE>female</VALUE>
      </SAMPLE_ATTRIBUTE>
    </SAMPLE_ATTRIBUTES>
  </SAMPLE>
  <SAMPLE alias="SAMEA5883873" accession="ERS3672329">
    <IDENTIFIERS>
      <PRIMARY_ID>ERS3672329</PRIMARY_ID>
      <EXTERNAL_ID namespace="BioSample">SAMEA5883873</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>PR097_S15</TITLE>
    <SAMPLE_NAME>
      <TAXON_ID>9606</TAXON_ID>
      <SCIENTIFIC_NAME>Homo sapiens</SCIENTIFIC_NAME>
    </SAMPLE_NAME>
    <DESCRIPTION>Protocols: Close contacts of patients with active tuberculosis (TB) were recruited from multiple TB clinics in London. At enrolment, peripheral blood RNA was collected into Tempus tubes. Total blood RNA was extracted using the Tempus Spin RNA Isolation Kit (Ambion; Life Technologies). Globin mRNA and genomic DNA were removed using the GlobinClear kit (Life Technologies) and the TURBO DNAfree kit (Ambion, Life Technologies), respectively. cDNA libraries were generated using the Kapa mRNA Hyperprep kit (Roche).</DESCRIPTION>
    <SAMPLE_ATTRIBUTES>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-FIRST-PUBLIC</TAG>
        <VALUE>2019-08-23T17:03:50Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-LAST-UPDATE</TAG>
        <VALUE>2019-08-23T10:24:59Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>External Id</TAG>
        <VALUE>SAMEA5883873</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC center name</TAG>
        <VALUE>UCL Infection&amp;Immunity Division</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC first public</TAG>
        <VALUE>2019-08-23T17:03:50Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC last update</TAG>
        <VALUE>2019-08-23T10:24:59Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC status</TAG>
        <VALUE>public</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>Submitter Id</TAG>
        <VALUE>E-MTAB-68451566551630:PR097_S15</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>age</TAG>
        <VALUE>29</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>broker name</TAG>
        <VALUE>ArrayExpress</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>common name</TAG>
        <VALUE>human</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>interferon gamma release assay</TAG>
        <VALUE>negative</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>organism part</TAG>
        <VALUE>blood</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>preventative tuberculosis treatment</TAG>
        <VALUE>no</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>progressor status (median follow-up 1.9 years)</TAG>
        <VALUE>non-progressor</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>progressor status (median follow-up 346 days)</TAG>
        <VALUE>non-progressor</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>roe et al 2019 subset (median follow-up 346 days)</TAG>
        <VALUE>no</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sample name</TAG>
        <VALUE>E-MTAB-68451566551630:PR097_S15</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>scientific_name</TAG>
        <VALUE>Homo sapiens</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sex</TAG>
        <VALUE>male</VALUE>
      </SAMPLE_ATTRIBUTE>
    </SAMPLE_ATTRIBUTES>
  </SAMPLE>
  <SAMPLE alias="SAMEA5883874" accession="ERS3672330">
    <IDENTIFIERS>
      <PRIMARY_ID>ERS3672330</PRIMARY_ID>
      <EXTERNAL_ID namespace="BioSample">SAMEA5883874</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>PR350_S15</TITLE>
    <SAMPLE_NAME>
      <TAXON_ID>9606</TAXON_ID>
      <SCIENTIFIC_NAME>Homo sapiens</SCIENTIFIC_NAME>
    </SAMPLE_NAME>
    <DESCRIPTION>Protocols: Close contacts of patients with active tuberculosis (TB) were recruited from multiple TB clinics in London. At enrolment, peripheral blood RNA was collected into Tempus tubes. Total blood RNA was extracted using the Tempus Spin RNA Isolation Kit (Ambion; Life Technologies). Globin mRNA and genomic DNA were removed using the GlobinClear kit (Life Technologies) and the TURBO DNAfree kit (Ambion, Life Technologies), respectively. cDNA libraries were generated using the Kapa mRNA Hyperprep kit (Roche).</DESCRIPTION>
    <SAMPLE_ATTRIBUTES>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-FIRST-PUBLIC</TAG>
        <VALUE>2019-08-23T17:03:50Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-LAST-UPDATE</TAG>
        <VALUE>2019-08-23T10:24:59Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>External Id</TAG>
        <VALUE>SAMEA5883874</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC center name</TAG>
        <VALUE>UCL Infection&amp;Immunity Division</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC first public</TAG>
        <VALUE>2019-08-23T17:03:50Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC last update</TAG>
        <VALUE>2019-08-23T10:24:59Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC status</TAG>
        <VALUE>public</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>Submitter Id</TAG>
        <VALUE>E-MTAB-68451566551630:PR350_S15</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>age</TAG>
        <VALUE>28</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>broker name</TAG>
        <VALUE>ArrayExpress</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>common name</TAG>
        <VALUE>human</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>interferon gamma release assay</TAG>
        <VALUE>positive</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>organism part</TAG>
        <VALUE>blood</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>preventative tuberculosis treatment</TAG>
        <VALUE>yes</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>progressor status (median follow-up 1.9 years)</TAG>
        <VALUE>non-progressor</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>progressor status (median follow-up 346 days)</TAG>
        <VALUE>non-progressor</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>roe et al 2019 subset (median follow-up 346 days)</TAG>
        <VALUE>no</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sample name</TAG>
        <VALUE>E-MTAB-68451566551630:PR350_S15</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>scientific_name</TAG>
        <VALUE>Homo sapiens</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sex</TAG>
        <VALUE>male</VALUE>
      </SAMPLE_ATTRIBUTE>
    </SAMPLE_ATTRIBUTES>
  </SAMPLE>
  <SAMPLE alias="SAMEA5883875" accession="ERS3672331">
    <IDENTIFIERS>
      <PRIMARY_ID>ERS3672331</PRIMARY_ID>
      <EXTERNAL_ID namespace="BioSample">SAMEA5883875</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>PR162_S17</TITLE>
    <SAMPLE_NAME>
      <TAXON_ID>9606</TAXON_ID>
      <SCIENTIFIC_NAME>Homo sapiens</SCIENTIFIC_NAME>
    </SAMPLE_NAME>
    <DESCRIPTION>Protocols: Close contacts of patients with active tuberculosis (TB) were recruited from multiple TB clinics in London. At enrolment, peripheral blood RNA was collected into Tempus tubes. Total blood RNA was extracted using the Tempus Spin RNA Isolation Kit (Ambion; Life Technologies). Globin mRNA and genomic DNA were removed using the GlobinClear kit (Life Technologies) and the TURBO DNAfree kit (Ambion, Life Technologies), respectively. cDNA libraries were generated using the Kapa mRNA Hyperprep kit (Roche).</DESCRIPTION>
    <SAMPLE_ATTRIBUTES>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-FIRST-PUBLIC</TAG>
        <VALUE>2019-08-23T17:03:50Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-LAST-UPDATE</TAG>
        <VALUE>2019-08-23T10:24:59Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>External Id</TAG>
        <VALUE>SAMEA5883875</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC center name</TAG>
        <VALUE>UCL Infection&amp;Immunity Division</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC first public</TAG>
        <VALUE>2019-08-23T17:03:50Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC last update</TAG>
        <VALUE>2019-08-23T10:24:59Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC status</TAG>
        <VALUE>public</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>Submitter Id</TAG>
        <VALUE>E-MTAB-68451566551630:PR162_S17</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>age</TAG>
        <VALUE>26</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>broker name</TAG>
        <VALUE>ArrayExpress</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>common name</TAG>
        <VALUE>human</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>interferon gamma release assay</TAG>
        <VALUE>negative</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>organism part</TAG>
        <VALUE>blood</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>preventative tuberculosis treatment</TAG>
        <VALUE>no</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>progressor status (median follow-up 1.9 years)</TAG>
        <VALUE>non-progressor</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>progressor status (median follow-up 346 days)</TAG>
        <VALUE>non-progressor</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>roe et al 2019 subset (median follow-up 346 days)</TAG>
        <VALUE>no</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sample name</TAG>
        <VALUE>E-MTAB-68451566551630:PR162_S17</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>scientific_name</TAG>
        <VALUE>Homo sapiens</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sex</TAG>
        <VALUE>female</VALUE>
      </SAMPLE_ATTRIBUTE>
    </SAMPLE_ATTRIBUTES>
  </SAMPLE>
  <SAMPLE alias="SAMEA5883876" accession="ERS3672332">
    <IDENTIFIERS>
      <PRIMARY_ID>ERS3672332</PRIMARY_ID>
      <EXTERNAL_ID namespace="BioSample">SAMEA5883876</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>PR239_S20</TITLE>
    <SAMPLE_NAME>
      <TAXON_ID>9606</TAXON_ID>
      <SCIENTIFIC_NAME>Homo sapiens</SCIENTIFIC_NAME>
    </SAMPLE_NAME>
    <DESCRIPTION>Protocols: Close contacts of patients with active tuberculosis (TB) were recruited from multiple TB clinics in London. At enrolment, peripheral blood RNA was collected into Tempus tubes. Total blood RNA was extracted using the Tempus Spin RNA Isolation Kit (Ambion; Life Technologies). Globin mRNA and genomic DNA were removed using the GlobinClear kit (Life Technologies) and the TURBO DNAfree kit (Ambion, Life Technologies), respectively. cDNA libraries were generated using the Kapa mRNA Hyperprep kit (Roche).</DESCRIPTION>
    <SAMPLE_ATTRIBUTES>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-FIRST-PUBLIC</TAG>
        <VALUE>2019-08-23T17:03:50Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-LAST-UPDATE</TAG>
        <VALUE>2019-08-23T10:24:59Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>External Id</TAG>
        <VALUE>SAMEA5883876</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC center name</TAG>
        <VALUE>UCL Infection&amp;Immunity Division</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC first public</TAG>
        <VALUE>2019-08-23T17:03:50Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC last update</TAG>
        <VALUE>2019-08-23T10:24:59Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC status</TAG>
        <VALUE>public</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>Submitter Id</TAG>
        <VALUE>E-MTAB-68451566551630:PR239_S20</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>age</TAG>
        <VALUE>17</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>broker name</TAG>
        <VALUE>ArrayExpress</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>common name</TAG>
        <VALUE>human</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>interferon gamma release assay</TAG>
        <VALUE>negative</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>organism part</TAG>
        <VALUE>blood</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>preventative tuberculosis treatment</TAG>
        <VALUE>no</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>progressor status (median follow-up 1.9 years)</TAG>
        <VALUE>non-progressor</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>progressor status (median follow-up 346 days)</TAG>
        <VALUE>non-progressor</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>roe et al 2019 subset (median follow-up 346 days)</TAG>
        <VALUE>no</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sample name</TAG>
        <VALUE>E-MTAB-68451566551630:PR239_S20</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>scientific_name</TAG>
        <VALUE>Homo sapiens</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sex</TAG>
        <VALUE>male</VALUE>
      </SAMPLE_ATTRIBUTE>
    </SAMPLE_ATTRIBUTES>
  </SAMPLE>
  <SAMPLE alias="SAMEA5883877" accession="ERS3672333">
    <IDENTIFIERS>
      <PRIMARY_ID>ERS3672333</PRIMARY_ID>
      <EXTERNAL_ID namespace="BioSample">SAMEA5883877</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>PR198_S2</TITLE>
    <SAMPLE_NAME>
      <TAXON_ID>9606</TAXON_ID>
      <SCIENTIFIC_NAME>Homo sapiens</SCIENTIFIC_NAME>
    </SAMPLE_NAME>
    <DESCRIPTION>Protocols: Close contacts of patients with active tuberculosis (TB) were recruited from multiple TB clinics in London. At enrolment, peripheral blood RNA was collected into Tempus tubes. Total blood RNA was extracted using the Tempus Spin RNA Isolation Kit (Ambion; Life Technologies). Globin mRNA and genomic DNA were removed using the GlobinClear kit (Life Technologies) and the TURBO DNAfree kit (Ambion, Life Technologies), respectively. cDNA libraries were generated using the Kapa mRNA Hyperprep kit (Roche).</DESCRIPTION>
    <SAMPLE_ATTRIBUTES>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-FIRST-PUBLIC</TAG>
        <VALUE>2019-08-23T17:03:50Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-LAST-UPDATE</TAG>
        <VALUE>2019-08-23T10:24:59Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>External Id</TAG>
        <VALUE>SAMEA5883877</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC center name</TAG>
        <VALUE>UCL Infection&amp;Immunity Division</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC first public</TAG>
        <VALUE>2019-08-23T17:03:50Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC last update</TAG>
        <VALUE>2019-08-23T10:24:59Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC status</TAG>
        <VALUE>public</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>Submitter Id</TAG>
        <VALUE>E-MTAB-68451566551630:PR198_S2</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>age</TAG>
        <VALUE>22</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>broker name</TAG>
        <VALUE>ArrayExpress</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>common name</TAG>
        <VALUE>human</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>interferon gamma release assay</TAG>
        <VALUE>negative</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>organism part</TAG>
        <VALUE>blood</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>preventative tuberculosis treatment</TAG>
        <VALUE>no</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>progressor status (median follow-up 1.9 years)</TAG>
        <VALUE>non-progressor</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>progressor status (median follow-up 346 days)</TAG>
        <VALUE>non-progressor</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>roe et al 2019 subset (median follow-up 346 days)</TAG>
        <VALUE>no</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sample name</TAG>
        <VALUE>E-MTAB-68451566551630:PR198_S2</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>scientific_name</TAG>
        <VALUE>Homo sapiens</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sex</TAG>
        <VALUE>male</VALUE>
      </SAMPLE_ATTRIBUTE>
    </SAMPLE_ATTRIBUTES>
  </SAMPLE>
  <SAMPLE alias="SAMEA5883878" accession="ERS3672334">
    <IDENTIFIERS>
      <PRIMARY_ID>ERS3672334</PRIMARY_ID>
      <EXTERNAL_ID namespace="BioSample">SAMEA5883878</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>PR062_S19</TITLE>
    <SAMPLE_NAME>
      <TAXON_ID>9606</TAXON_ID>
      <SCIENTIFIC_NAME>Homo sapiens</SCIENTIFIC_NAME>
    </SAMPLE_NAME>
    <DESCRIPTION>Protocols: Close contacts of patients with active tuberculosis (TB) were recruited from multiple TB clinics in London. At enrolment, peripheral blood RNA was collected into Tempus tubes. Total blood RNA was extracted using the Tempus Spin RNA Isolation Kit (Ambion; Life Technologies). Globin mRNA and genomic DNA were removed using the GlobinClear kit (Life Technologies) and the TURBO DNAfree kit (Ambion, Life Technologies), respectively. cDNA libraries were generated using the Kapa mRNA Hyperprep kit (Roche).</DESCRIPTION>
    <SAMPLE_ATTRIBUTES>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-FIRST-PUBLIC</TAG>
        <VALUE>2019-08-23T17:03:50Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-LAST-UPDATE</TAG>
        <VALUE>2019-08-23T10:24:59Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>External Id</TAG>
        <VALUE>SAMEA5883878</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC center name</TAG>
        <VALUE>UCL Infection&amp;Immunity Division</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC first public</TAG>
        <VALUE>2019-08-23T17:03:50Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC last update</TAG>
        <VALUE>2019-08-23T10:24:59Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC status</TAG>
        <VALUE>public</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>Submitter Id</TAG>
        <VALUE>E-MTAB-68451566551630:PR062_S19</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>age</TAG>
        <VALUE>35</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>broker name</TAG>
        <VALUE>ArrayExpress</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>common name</TAG>
        <VALUE>human</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>interferon gamma release assay</TAG>
        <VALUE>positive</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>organism part</TAG>
        <VALUE>blood</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>preventative tuberculosis treatment</TAG>
        <VALUE>yes</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>progressor status (median follow-up 1.9 years)</TAG>
        <VALUE>non-progressor</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>progressor status (median follow-up 346 days)</TAG>
        <VALUE>non-progressor</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>roe et al 2019 subset (median follow-up 346 days)</TAG>
        <VALUE>yes</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sample name</TAG>
        <VALUE>E-MTAB-68451566551630:PR062_S19</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>scientific_name</TAG>
        <VALUE>Homo sapiens</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sex</TAG>
        <VALUE>male</VALUE>
      </SAMPLE_ATTRIBUTE>
    </SAMPLE_ATTRIBUTES>
  </SAMPLE>
  <SAMPLE alias="SAMEA5883879" accession="ERS3672335">
    <IDENTIFIERS>
      <PRIMARY_ID>ERS3672335</PRIMARY_ID>
      <EXTERNAL_ID namespace="BioSample">SAMEA5883879</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>PR034_S7</TITLE>
    <SAMPLE_NAME>
      <TAXON_ID>9606</TAXON_ID>
      <SCIENTIFIC_NAME>Homo sapiens</SCIENTIFIC_NAME>
    </SAMPLE_NAME>
    <DESCRIPTION>Protocols: Close contacts of patients with active tuberculosis (TB) were recruited from multiple TB clinics in London. At enrolment, peripheral blood RNA was collected into Tempus tubes. Total blood RNA was extracted using the Tempus Spin RNA Isolation Kit (Ambion; Life Technologies). Globin mRNA and genomic DNA were removed using the GlobinClear kit (Life Technologies) and the TURBO DNAfree kit (Ambion, Life Technologies), respectively. cDNA libraries were generated using the Kapa mRNA Hyperprep kit (Roche).</DESCRIPTION>
    <SAMPLE_ATTRIBUTES>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-FIRST-PUBLIC</TAG>
        <VALUE>2019-08-23T17:03:50Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-LAST-UPDATE</TAG>
        <VALUE>2019-08-23T10:24:59Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>External Id</TAG>
        <VALUE>SAMEA5883879</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC center name</TAG>
        <VALUE>UCL Infection&amp;Immunity Division</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC first public</TAG>
        <VALUE>2019-08-23T17:03:50Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC last update</TAG>
        <VALUE>2019-08-23T10:24:59Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC status</TAG>
        <VALUE>public</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>Submitter Id</TAG>
        <VALUE>E-MTAB-68451566551630:PR034_S7</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>age</TAG>
        <VALUE>31</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>broker name</TAG>
        <VALUE>ArrayExpress</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>common name</TAG>
        <VALUE>human</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>interferon gamma release assay</TAG>
        <VALUE>positive</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>organism part</TAG>
        <VALUE>blood</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>preventative tuberculosis treatment</TAG>
        <VALUE>yes</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>progressor status (median follow-up 1.9 years)</TAG>
        <VALUE>non-progressor</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>progressor status (median follow-up 346 days)</TAG>
        <VALUE>non-progressor</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>roe et al 2019 subset (median follow-up 346 days)</TAG>
        <VALUE>yes</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sample name</TAG>
        <VALUE>E-MTAB-68451566551630:PR034_S7</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>scientific_name</TAG>
        <VALUE>Homo sapiens</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sex</TAG>
        <VALUE>male</VALUE>
      </SAMPLE_ATTRIBUTE>
    </SAMPLE_ATTRIBUTES>
  </SAMPLE>
  <SAMPLE alias="SAMEA5883880" accession="ERS3672336">
    <IDENTIFIERS>
      <PRIMARY_ID>ERS3672336</PRIMARY_ID>
      <EXTERNAL_ID namespace="BioSample">SAMEA5883880</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>PR009_S2</TITLE>
    <SAMPLE_NAME>
      <TAXON_ID>9606</TAXON_ID>
      <SCIENTIFIC_NAME>Homo sapiens</SCIENTIFIC_NAME>
    </SAMPLE_NAME>
    <DESCRIPTION>Protocols: Close contacts of patients with active tuberculosis (TB) were recruited from multiple TB clinics in London. At enrolment, peripheral blood RNA was collected into Tempus tubes. Total blood RNA was extracted using the Tempus Spin RNA Isolation Kit (Ambion; Life Technologies). Globin mRNA and genomic DNA were removed using the GlobinClear kit (Life Technologies) and the TURBO DNAfree kit (Ambion, Life Technologies), respectively. cDNA libraries were generated using the Kapa mRNA Hyperprep kit (Roche).</DESCRIPTION>
    <SAMPLE_ATTRIBUTES>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-FIRST-PUBLIC</TAG>
        <VALUE>2019-08-23T17:03:50Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-LAST-UPDATE</TAG>
        <VALUE>2019-08-23T10:24:59Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>External Id</TAG>
        <VALUE>SAMEA5883880</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC center name</TAG>
        <VALUE>UCL Infection&amp;Immunity Division</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC first public</TAG>
        <VALUE>2019-08-23T17:03:50Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC last update</TAG>
        <VALUE>2019-08-23T10:24:59Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC status</TAG>
        <VALUE>public</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>Submitter Id</TAG>
        <VALUE>E-MTAB-68451566551630:PR009_S2</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>age</TAG>
        <VALUE>19</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>broker name</TAG>
        <VALUE>ArrayExpress</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>common name</TAG>
        <VALUE>human</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>interferon gamma release assay</TAG>
        <VALUE>positive</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>organism part</TAG>
        <VALUE>blood</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>preventative tuberculosis treatment</TAG>
        <VALUE>yes</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>progressor status (median follow-up 1.9 years)</TAG>
        <VALUE>non-progressor</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>progressor status (median follow-up 346 days)</TAG>
        <VALUE>non-progressor</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>roe et al 2019 subset (median follow-up 346 days)</TAG>
        <VALUE>yes</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sample name</TAG>
        <VALUE>E-MTAB-68451566551630:PR009_S2</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>scientific_name</TAG>
        <VALUE>Homo sapiens</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sex</TAG>
        <VALUE>female</VALUE>
      </SAMPLE_ATTRIBUTE>
    </SAMPLE_ATTRIBUTES>
  </SAMPLE>
  <SAMPLE alias="SAMEA5883881" accession="ERS3672337">
    <IDENTIFIERS>
      <PRIMARY_ID>ERS3672337</PRIMARY_ID>
      <EXTERNAL_ID namespace="BioSample">SAMEA5883881</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>PR085_S11</TITLE>
    <SAMPLE_NAME>
      <TAXON_ID>9606</TAXON_ID>
      <SCIENTIFIC_NAME>Homo sapiens</SCIENTIFIC_NAME>
    </SAMPLE_NAME>
    <DESCRIPTION>Protocols: Close contacts of patients with active tuberculosis (TB) were recruited from multiple TB clinics in London. At enrolment, peripheral blood RNA was collected into Tempus tubes. Total blood RNA was extracted using the Tempus Spin RNA Isolation Kit (Ambion; Life Technologies). Globin mRNA and genomic DNA were removed using the GlobinClear kit (Life Technologies) and the TURBO DNAfree kit (Ambion, Life Technologies), respectively. cDNA libraries were generated using the Kapa mRNA Hyperprep kit (Roche).</DESCRIPTION>
    <SAMPLE_ATTRIBUTES>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-FIRST-PUBLIC</TAG>
        <VALUE>2019-08-23T17:03:50Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-LAST-UPDATE</TAG>
        <VALUE>2019-08-23T10:24:59Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>External Id</TAG>
        <VALUE>SAMEA5883881</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC center name</TAG>
        <VALUE>UCL Infection&amp;Immunity Division</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC first public</TAG>
        <VALUE>2019-08-23T17:03:50Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC last update</TAG>
        <VALUE>2019-08-23T10:24:59Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC status</TAG>
        <VALUE>public</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>Submitter Id</TAG>
        <VALUE>E-MTAB-68451566551630:PR085_S11</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>age</TAG>
        <VALUE>23</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>broker name</TAG>
        <VALUE>ArrayExpress</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>common name</TAG>
        <VALUE>human</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>interferon gamma release assay</TAG>
        <VALUE>positive</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>organism part</TAG>
        <VALUE>blood</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>preventative tuberculosis treatment</TAG>
        <VALUE>yes</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>progressor status (median follow-up 1.9 years)</TAG>
        <VALUE>non-progressor</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>progressor status (median follow-up 346 days)</TAG>
        <VALUE>non-progressor</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>roe et al 2019 subset (median follow-up 346 days)</TAG>
        <VALUE>yes</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sample name</TAG>
        <VALUE>E-MTAB-68451566551630:PR085_S11</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>scientific_name</TAG>
        <VALUE>Homo sapiens</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sex</TAG>
        <VALUE>female</VALUE>
      </SAMPLE_ATTRIBUTE>
    </SAMPLE_ATTRIBUTES>
  </SAMPLE>
  <SAMPLE alias="SAMEA5883882" accession="ERS3672338">
    <IDENTIFIERS>
      <PRIMARY_ID>ERS3672338</PRIMARY_ID>
      <EXTERNAL_ID namespace="BioSample">SAMEA5883882</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>PR165_S15</TITLE>
    <SAMPLE_NAME>
      <TAXON_ID>9606</TAXON_ID>
      <SCIENTIFIC_NAME>Homo sapiens</SCIENTIFIC_NAME>
    </SAMPLE_NAME>
    <DESCRIPTION>Protocols: Close contacts of patients with active tuberculosis (TB) were recruited from multiple TB clinics in London. At enrolment, peripheral blood RNA was collected into Tempus tubes. Total blood RNA was extracted using the Tempus Spin RNA Isolation Kit (Ambion; Life Technologies). Globin mRNA and genomic DNA were removed using the GlobinClear kit (Life Technologies) and the TURBO DNAfree kit (Ambion, Life Technologies), respectively. cDNA libraries were generated using the Kapa mRNA Hyperprep kit (Roche).</DESCRIPTION>
    <SAMPLE_ATTRIBUTES>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-FIRST-PUBLIC</TAG>
        <VALUE>2019-08-23T17:03:50Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-LAST-UPDATE</TAG>
        <VALUE>2019-08-23T10:24:59Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>External Id</TAG>
        <VALUE>SAMEA5883882</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC center name</TAG>
        <VALUE>UCL Infection&amp;Immunity Division</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC first public</TAG>
        <VALUE>2019-08-23T17:03:50Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC last update</TAG>
        <VALUE>2019-08-23T10:24:59Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC status</TAG>
        <VALUE>public</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>Submitter Id</TAG>
        <VALUE>E-MTAB-68451566551630:PR165_S15</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>age</TAG>
        <VALUE>29</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>broker name</TAG>
        <VALUE>ArrayExpress</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>common name</TAG>
        <VALUE>human</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>interferon gamma release assay</TAG>
        <VALUE>positive</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>organism part</TAG>
        <VALUE>blood</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>preventative tuberculosis treatment</TAG>
        <VALUE>yes</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>progressor status (median follow-up 1.9 years)</TAG>
        <VALUE>non-progressor</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>progressor status (median follow-up 346 days)</TAG>
        <VALUE>non-progressor</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>roe et al 2019 subset (median follow-up 346 days)</TAG>
        <VALUE>yes</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sample name</TAG>
        <VALUE>E-MTAB-68451566551630:PR165_S15</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>scientific_name</TAG>
        <VALUE>Homo sapiens</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sex</TAG>
        <VALUE>female</VALUE>
      </SAMPLE_ATTRIBUTE>
    </SAMPLE_ATTRIBUTES>
  </SAMPLE>
  <SAMPLE alias="SAMEA5883883" accession="ERS3672339">
    <IDENTIFIERS>
      <PRIMARY_ID>ERS3672339</PRIMARY_ID>
      <EXTERNAL_ID namespace="BioSample">SAMEA5883883</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>PR121_S18</TITLE>
    <SAMPLE_NAME>
      <TAXON_ID>9606</TAXON_ID>
      <SCIENTIFIC_NAME>Homo sapiens</SCIENTIFIC_NAME>
    </SAMPLE_NAME>
    <DESCRIPTION>Protocols: Close contacts of patients with active tuberculosis (TB) were recruited from multiple TB clinics in London. At enrolment, peripheral blood RNA was collected into Tempus tubes. Total blood RNA was extracted using the Tempus Spin RNA Isolation Kit (Ambion; Life Technologies). Globin mRNA and genomic DNA were removed using the GlobinClear kit (Life Technologies) and the TURBO DNAfree kit (Ambion, Life Technologies), respectively. cDNA libraries were generated using the Kapa mRNA Hyperprep kit (Roche).</DESCRIPTION>
    <SAMPLE_ATTRIBUTES>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-FIRST-PUBLIC</TAG>
        <VALUE>2019-08-23T17:03:50Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-LAST-UPDATE</TAG>
        <VALUE>2019-08-23T10:24:59Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>External Id</TAG>
        <VALUE>SAMEA5883883</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC center name</TAG>
        <VALUE>UCL Infection&amp;Immunity Division</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC first public</TAG>
        <VALUE>2019-08-23T17:03:50Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC last update</TAG>
        <VALUE>2019-08-23T10:24:59Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC status</TAG>
        <VALUE>public</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>Submitter Id</TAG>
        <VALUE>E-MTAB-68451566551630:PR121_S18</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>age</TAG>
        <VALUE>31</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>broker name</TAG>
        <VALUE>ArrayExpress</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>common name</TAG>
        <VALUE>human</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>interferon gamma release assay</TAG>
        <VALUE>positive</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>organism part</TAG>
        <VALUE>blood</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>preventative tuberculosis treatment</TAG>
        <VALUE>yes</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>progressor status (median follow-up 1.9 years)</TAG>
        <VALUE>non-progressor</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>progressor status (median follow-up 346 days)</TAG>
        <VALUE>non-progressor</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>roe et al 2019 subset (median follow-up 346 days)</TAG>
        <VALUE>yes</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sample name</TAG>
        <VALUE>E-MTAB-68451566551630:PR121_S18</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>scientific_name</TAG>
        <VALUE>Homo sapiens</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sex</TAG>
        <VALUE>male</VALUE>
      </SAMPLE_ATTRIBUTE>
    </SAMPLE_ATTRIBUTES>
  </SAMPLE>
</SAMPLE_SET>
